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PREFACE 
Magnetic resonance imaging is widely used as a diagnostic tool in clinical settings. Being 
non-invasive and non-ionizing makes it an ideal method to image human subjects in both cross-
sectional and longitudinal studies. In the past decade, susceptibility weighted imaging (SWI) has 
received a great deal of attention in both the research and clinical realms. Due to its new source 
of contrast compared to conventional MRI, SWI offers new directions in studying the brain and 
its vasculature as well as imaging magnetic material (such as iron). Imaging iron is important 
because it is thought to be associated with normal aging and some neurodegenerative disease. 
For example, in multiple sclerosis (MS), a complex autoimmune neurodegenerative disease, iron 
involvement has been reported in patients both in vivo and post mortem. This iron deposition is 
believed to be not only associated with the inflammatory process in MS but also with vascular 
abnormalities in the brain and neck.   
In this work, we will first validate the ability of SWI to create contrast based on local iron 
content and we will use this technique to evaluate iron content in MS patients compared to 
normal (healthy) subjects. We will present a new means to extract iron content in large areas, 
which eliminates the effect of averaging (previously used) on data assessment. Finally, in order 
to study the relation between increased iron content, lesion load and the new theory of vascular 
involvement in MS (mentioned above), we will introduce the possibility of developing a vascular 
animal model of MS, by emphasizing the similarities and differences in the human and swine 
venous drainage system and presenting some preliminary data toward that direction.  
  
 vi 
 
TABLE OF CONTENTS 
Dedication --------------------------------------------------------------------------------------------------- ii 
Acknowledgments ------------------------------------------------------------------------------------------ iii 
Preface ------------------------------------------------------------------------------------------------------- v 
List of Tables  ---------------------------------------------------------------------------------------------- viii 
List of Figures  ---------------------------------------------------------------------------------------------- ix 
Abbreviation List ------------------------------------------------------------------------------------------- xi 
Chapter 1 – Introduction 
 1.1 – Background and Project Motivation -------------------------------------------- 1 
 1.2 – Project Aims ----------------------------------------------------------------------- 4 
Chapter 2 – Iron in the Brain ----------------------------------------------------------------------------- 5 
 2.1 – Iron Types -------------------------------------------------------------------------- 7 
 2.2 – Iron Distribution in the Brain ---------------------------------------------------- 8 
 2.3 – Iron and Age ----------------------------------------------------------------------- 9 
 2.4 – Iron and Neurodegenerative Disease ------------------------------------------- 10 
 2.5 – Iron as Seen with MRI ------------------------------------------------------------ 13 
Chapter 3 – Susceptibility Weighted Imaging --------------------------------------------------------- 17 
 3.1 – Magnetic Susceptibility ---------------------------------------------------------- 19 
 3.2 – Gradient Echo ---------------------------------------------------------------------- 21 
 3.3 – Susceptibility Weighted Imaging ----------------------------------------------- 26 
 3.4 – SWI filtered Phase Images ------------------------------------------------------- 28 
Chapter 4 – Characterizing the Mesencephalon Using Susceptibility Weighted Imaging ------- 32 
 
 
 vii 
 
Chapter 5 – Multiple Sclerosis --------------------------------------------------------------------------- 45 
 5.1 – Different Types of MS ------------------------------------------------------------ 46 
 5.2 – MS Patients ------------------------------------------------------------------------- 49 
 5.3 – Immunological Approach -------------------------------------------------------- 52 
 5.4 – Cellular Approach ----------------------------------------------------------------- 56 
 5.5 – Molecular Approach -------------------------------------------------------------- 58 
 5.6 – Vascular Involvement in MS ---------------------------------------------------- 60 
 5.7 – Neuronal Involvement in MS ---------------------------------------------------- 61 
 5.8 – Correlational Interpretations ----------------------------------------------------- 68 
Chapter 6 – Visualizing Iron Deposition in Multiple Sclerosis Cadaver Brains ------------------ 72 
Chapter 7 – Assessing Iron Content in the Deep Gray Matter of MS Patients and 
 Healthy Controls ------------------------------------------------------------------------- 80 
Chapter 8 – Cerebral Vasculature of Swine as a Probable Model for Neurodegenerative  
 Disease ------------------------------------------------------------------------------------- 95 
Chapter 9 – Conclusions and Future Directions ------------------------------------------------------- 116 
Appendix A: Phase Contrast Quantitative Flow Imaging -------------------------------------------- 120 
Appendix B: Progress to Date on the Vascular Animal Model of MS ----------------------------- 123 
Appendix C: The John Wiley and Sons License Terms and Conditions --------------------------- 125 
Appendix D: The American Journal of Neuroradiology Editor’s Permissions -------------------- 132 
References ----  ---------------------------------------------------------------------------------------------- 133 
Abstract ------------------------------------------------------------------------------------------------------ 162 
Autobiographical Statement ------------------------------------------------------------------------------ 164 
 
 viii 
 
LIST OF TABLES 
Table 3.1: Expressions for field inside and outside a uniform sphere and an infinitely long 
cylinder ----------------------------------------------------------------------------------------- 21 
 
Table 4.1: 1.5 T contrast-to-noise ratio (CNR) measurements -------------------------------------- 42 
Table 4.2: 4T contrast-to-noise ratio (CNR) measurements ----------------------------------------- 42 
Table 7.1: Abnormal iron deposition weighting ------------------------------------------------------- 91  
Table 7.2: Total and subtotal iron content weightings of all the four structures ------------------ 92 
Table 8.1: Imaging parameters for the sequences collected during MR scanning ---------------- 108 
Table 8.2: Quantitative flow measurements acquired at multiple levels in the head and neck 
for the male pig ------------------------------------------------------------------------------- 109 
 
Table 8.3: Comparison of the distribution of flow through the major veins of the neck for all 
three pigs --------------------------------------------------------------------------------------- 110 
 
 ix 
 
LIST OF FIGURES 
Figure 2.1: The heme cofactor of the protein hemoglobin ------------------------------------------- 6 
Figure 2.2: Ferritin molecules store thousands of iron atoms within their mineral core --------- 7 
Figure 3.1: Steps involved in creating SW Images ---------------------------------------------------- 18 
Figure 3.2: Free induction decay ------------------------------------------------------------------------- 23 
Figure 3.3: 1D gradient echo experiment --------------------------------------------------------------- 24 
Figure 3.4: Original sequence diagram for SWI with flow compensation ------------------------- 27 
Figure 3.5: SWI magnitude and phase images --------------------------------------------------------- 28 
Figure 3.6: High pass filters ------------------------------------------------------------------------------ 30 
Figure 3.7: Magnitude, phase and SWI images -------------------------------------------------------- 31 
Figure 4.1: The midbrain ---------------------------------------------------------------------------------- 39 
Figure 4.2: A comparison of one region of the mesencephalon for different sequences and 
field strengths with Duvernoy's stained cadaver brain results ------------------------ 40 
 
Figure 4.3:  A comparison between adjacent slices in SWI magnitude and high-pass filtered 
phase images at 1.5T and 4T with Duvernoy's India ink-stained results ------------ 40 
 
Figure 4.4: A comparison of SWI high-pass filtered phase images with Duvernoy's India ink-
stained results -------------------------------------------------------------------------------- 41 
 
Figure 5.1: Multiple sclerosis lesion patterns ---------------------------------------------------------- 65 
Figure 5.2: Different types of MS lesions seen on SWI ---------------------------------------------- 66 
Figure 5.3: The three types of cortical lesions --------------------------------------------------------- 67 
Figure 6.1: Optical images of the two MS brains ------------------------------------------------------ 75 
Figure 6.2: Comparison between different acquired MRI sequences showing MS lesions, iron 
and zinc deposition in MS1 ---------------------------------------------------------------- 78 
 
Figure 7.1: SWI filtered phase images displaying the basal ganglia and the midbrain ---------- 87 
Figure 7.2: Average phase, normalized area and total phase of RII in CN and PT --------------- 88  
 x 
 
Figure 7.3: Plots showing individual weighting of different parameters of the pulvinar  
 thalamus and the red nucleus -------------------------------------------------------------- 89 
 
Figure 7.4: Four plots showing the subtotal weighting factors and the total weighting factor 
of the four structures with the weighting factor greater than 1 CN, PT, RN and 
SN ---------------------------------------------------------------------------------------------- 90 
 
Figure 8.1: The venous drainage system of the swine reported in the literature ------------------ 100 
Figure 8.2: T2 weighted images showing an axial cross section along the whole brain  -------- 101 
Figure 8.3: T1 weighted images showing an axial cross section along the whole brain --------- 101 
Figure 8.4: T1 weighted images showing coronal, axial and sagittal views ----------------------- 102 
Figure 8.5: Swine's cerebral vein structures ------------------------------------------------------------ 102 
Figure 8.6: Human and swine cerebral vasculature comparison ------------------------------------ 103 
Figure 8.7: 3D projection of the 2D MRV data set ---------------------------------------------------- 105 
Figure 8.8: Detailed anatomical description of the drainage system of the swine brain --------- 106 
Figure A.1: Typical Phase contrast Pulse Sequence--------------------------------------------------- 121 
Figure B.1: The venous drainage system pre and post-surgery -------------------------------------- 124 
 xi 
 
ABBREVIATION LIST 
 ADHD: Attention Deficit Hyperactivity Disorder 
 AFV:  Anterior Facial Vein 
 BBB: Blood Brain Barrier 
 BW:  Bandwidth 
 CC:  Crus Cerebri  
 CCSVI:  Chronic Cerebrospinal Venous Insufficiency 
 CIS: Clinically Isolated Syndrome 
 CMG:  Central aspect of Medial Geniculate body 
 CN:  Caudate Nucleus 
CNPase:  Cyclic Nucleotide Phosphodiesterase 
 CNR:  Contrast to Noise Ratio 
 CNS:  Central Nervous System 
 CSF:  Cerebrospinal Fluid 
 DMT-1:  Divalent Metal Transporter-1 
 DSS:  Dorsal Sagittal Sinus 
 EAE:  Experimental Autoimmune Encephalomyelitis 
 EJV:  External Jugular Veins 
 FA:  Flip Angle 
 FDRI:  Field-Dependent Relaxation Rate Increase  
 FLAIR:  Fluid Attenuated Inversion Recovery 
FLASH:  Fast Low Angle Shot 
 Foxp3:  Fork head box P3 transcription 
 GD:  Gadolinium 
 xii 
 
 GM:  Gray Matter 
 GP:  Globus Pallidus 
 GRE:  Gradient Recalled Echo 
 HP:  High Pass 
 HSB:  Human Brain and Spinal Fluid Resource Center 
 IA:  Intermediate Area between RN and SN 
 ICC:  Intra-Class Correlation Coefficient Reliability 
 IJV:  Internal Jugular Veins 
 IL: Interleukin 
 LFB:  Luxol Fast Blue 
 LMG: Lateral aspect of the Medial Geniculate body 
 MAG:  Myelin-Associated Glycoprotein 
 MFC:  Magnetic Field Correlation  
 MOG:  Myelin Oligodendrocyte Glycoprotein 
 MRA:  Magnetic Resonance Angiography 
 MRI:  Magnetic Resonance Imaging 
 MRV:  Magnetic Resonance Venography 
 MS:  Multiple Sclerosis 
NAWM:  Normal-Appearing White Matter 
 PC:  Phase-Contrast 
 PD:  Phase Difference 
 PPMS:  Primary Progressive Multiple Sclerosis 
 PRMS: Progressive Relapsing Multiple Sclerosis 
 xiii 
 
 PT:  Pulvinar Thalamus 
 PTA:  Percutaneous Transluminal Angioplasty 
 PUT:  Putamen 
 QSM:  Quantitative Susceptibility Mapping 
 rf:  Radiofrequency 
 RN:  Red Nucleus 
 ROI:  Region of Interest 
 RRMS:  Relapsing Remitting Multiple Sclerosis 
RSXRF:  Rapid Scanning X-Ray Fluorescence 
 SD:  Standard Deviation 
 SN:  Substantia Nigra 
 SNc:  Substantia Nigra, pars compacta 
 SNr:  Substantia Nigra, pars reticulata 
 SNR:  Signal to Noise Ratio 
 SPIN:  Signal Processing In Nuclear magnetic Resonance 
 SPMS:  Secondary Progressive Multiple Sclerosis 
 SPSS:  Statistical Package for Social Sciences 
 SS:  Straight Sinus 
 SSRL:  Stanford Synchrotron Radiation Lightsource 
 SWI:  Susceptibility Weighted Imaging  
 SWIM:  Susceptibility Weighted Imaging and  Mapping 
 T:  Tesla 
 T1:  Spin Lattice Relaxation Time 
 xiv 
 
 T2:  Spin-Spin Relaxation Time 
 Tf:  Transferrin 
 TE:  Echo Time 
 THA:  Thalamus 
 TOF:  Time Of Flight 
 TR:  Repetition Time 
 USPIO:  Ultra Small Superparamagnetic Particles Of Iron Oxide 
 νenc:  Velocity Encoding 
 VIBE:  Volumetric Interpolated Breath-Hold Sequence  
 VVVP:  Ventral Vertebral Venous Plexus 
 WM:  White Matter 
1 
 
 
Chapter One 
INTRODUCTION 
1.1. Background and Project Motivation 
Assessing normal human physiological processes and their pathology in vivo became 
possible with the advent of medical imaging techniques. Magnetic resonance imaging (MRI), in 
particular, is the technique of choice especially in longitudinal studies, since it is a non-invasive 
and non-ionizing imaging modality (and therefore safe) (Haacke et al. 1999). It has been shown 
to be sensitive and specific in imaging the human anatomy and function due to its high resolution 
(which is currently provided at a millimeter level). In most cases, human scanners use proton 
imaging. In this case, the source of signal for human MR images comes from the proton 
molecules in the body. Historically, contrast has been based on the spin density and relaxation 
properties of each tissue although today there are many other tissue properties that can now be 
imaged including tissue susceptibility  (Haacke et al. 2009). This latter property makes it 
possible to image iron.  
Iron, is a paramagnetic molecule, and is known to be the most abundant metal in the brain 
(Haacke et al., 2007). Its role in the biochemistry of the human body has made it an interesting 
substance for researchers to investigate including but not limited to its distribution, accumulation 
over time, and its abnormal deposition in many neurodegenerative diseases such as multiple 
sclerosis (Hare et al. 2013). 
Multiple sclerosis (MS) has long been defined as an inflammatory demyelinating 
autoimmune disease of the central nervous system (CNS) (Noseworthy et al., 2000b). What 
initiates the disease and the sequence of events underlying the development of MS is not yet well 
understood (Noseworthy et al., 2000b). However, technological progress has shed some 
2 
 
 
important insights on many of the factors involved in the pathology of this complex disease. The 
pathological landmarks of MS (structural and functional) are characterized by areas of 
demyelinated plaques mostly in white matter (WM) and altered global as well as local perfusion  
(Filippi et al., 1998; Haacke et al., 2009a). This is also observed to a lesser degree, in the cortical 
regions, specifically near the gray matter (GM)/WM boundary and in gray matter as well 
(Haacke et al., 2009a; Nelson et al., 2007). Determining whether the starting point is in the GM 
or WM remains unclear (Allen et al., 2001; Neema et al., 2009; Nelson et al., 2007). Finally iron 
accumulation has been reported predominantly in the deep gray matter (basal ganglia and 
midbrain) (Adams, 1988; Eissa et al., 2009; Filippi and Rocca, 2009; Haacke et al., 2009a; Varga 
et al., 2009).  
 Brain iron accumulation in MS has been shown histologically in the past (Craelius et al., 
1982; Levine and Chakrabarty, 2004). Iron deposition was seen in and around white matter 
lesions (mostly perivenular), in the deep gray matter area (basal ganglia and midbrain) and in an 
antegrade fashion along the venous drainage system (such as thalamostriate system) (Haacke et 
al. 2010). This has been hypothetically linked to a new theory known as chronic cerebrospinal 
venous insufficiency. This study showed that MS patients tend to have extracranial venous 
abnormalities such as obstruction of the internal jugular veins in the neck and the azygos vein 
along the thoracic vertebral column (Zamboni et al., 2009), (Haacke et al., 2012c). These 
abnormalities lead to alteration in the blood drainage from the brain and produce a hemodynamic 
effect which is thought to be related to the clinical outcomes of MS. These outcomes have 
increased the research community’s interest in assessing iron and flow involvement in MS which 
might provide clues to the link between white matter lesions, iron content and flow 
abnormalities. 
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The motivation for studying iron and its relation with vascular abnormalities in this thesis 
was therefore based on all the observations mentioned above. Specifically, I will address: 1) the 
ability of susceptibility weighted imaging in resolving the main structures and substructures of 
the midbrain which are thought to be affected in neurodegenerative diseases; 2) measuring iron 
content in MS patients with age matched healthy normal controls  in vivo as a means to develop a 
new imaging biomarker for MS; and 3) the possibility of developing a new MS vascular animal 
model to study the link between vascular abnormalities, iron deposition and sclerotic lesions.  
The remaining chapters in this thesis are arranged as follows.  Chapter two gives a 
detailed overview on iron in the body and the brain, its function under normal conditions and its 
involvement in many diseases (“when it behaves badly”). Chapter three presents the basics of the 
MR gradient echo concept and how it is used to generate susceptibility weighted magnitude and 
phase images (which will be used to visualize different structures of the brain and assess their 
iron content in MS patients and healthy controls). Chapter four uses high contrast SWI data to 
differentiate between basic mesecephalic structures including the red nucleus, the substantia 
nigra and the crus cerebri (paper published in AJNR). Chapter five describes the basics of what 
is known about MS and its clinical manifestation including white matter and gray matter lesions 
as well as iron deposition. Chapter six tests the specificity of SWI compared to X-Ray 
fluorescence in imaging iron content in MS cadaver brains (paper published in AIP). In chapter 
seven, iron in the basal ganglia and the midbrain is assessed using SWI and compared between 
healthy controls and MS patients (published in AJNR). Chapter eight presents part of our work 
on developing a new MS vascular animal model where we assess the similarities and differences 
in the venous drainage system between pigs and humans (published in JMRI). Finally, chapter 
nine discusses conclusions and future directions. 
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1.2. Project Aims: 
In this dissertation, MRI methods will be used to visualize and evaluate iron content in 
the basal ganglia and midbrain, to assess whether MS patients (in vivo and ex vivo) suffer from 
increased iron content in the brain and to evaluate the similarities between the cerebral 
vasculature of the swine and the human, as a means to develop a new vascular model for 
neurodegenerative diseases such as MS. The specific aims and hypotheses of this proposal are: 
Specific aim 1: To collect high-contrast SWI data to differentiate between and within the basic 
mesencephalic structures; namely, the red nucleus, substantia nigra and crus cerebri. 
Hypothesis: Using SWI, it is possible to create better anatomical images of the mesencephalon, 
with improved contrast compared to conventional T1 or T2-weighted sequences. 
Specific aim 2: To visualize and validate iron deposition using rapid scanning X‐Ray 
Fluorescence (RS‐XRF) and SWI in two MS cadaver brains. 
Hypothesis: XRF will show similar contrast as SWI and reveal perivascular iron deposition in 
MS lesions. 
Specific aim 3: To evaluate iron content in the basal ganglia and midbrain of MS patients using 
SWI and to compare the results to a previously established baseline of normal iron content as a 
function of age. 
Hypothesis: MS patients have much higher iron in the midbrain and basal ganglia than age 
matched normal controls. 
Specific aim 4: To investigate the similarities and differences between the human and pig 
(swine) cerebral vasculature using MR venography and angiography. 
Hypothesis: The swine brain’s vasculature and flow will be similar to that in humans, presenting 
the swine as a good large animal model to study the vascular aspects of MS. 
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Chapter Two 
IRON IN THE BRAIN 
Chapter Overview 
In this chapter, we explore the most abundant metal in the brain, iron, and we emphasize 
its importance in the body and in the brain. We describe its different types and their role based 
on their composition. The iron distribution in the brain and its relation with age are discussed. 
Pathological examples are given showing the potential role of abnormal iron level in 
neurological diseases. Finally, common magnetic resonance imaging methods that have been 
used to image and quantify iron in vivo are highlighted. 
 
Introduction 
Understanding the pathological role of iron in the brain has been one of the major focuses 
of neurological research for decades. Iron has been associated with the outcome and potential 
pathogenesis of many neurodegenerative diseases such as Friedrich’s ataxia, Huntington’s 
disease, multiple sclerosis, Parkinson’s disease and other iron related genetic diseases (Bartzokis 
et al., 1994; Beard et al., 1993; Connor and Menzies, 1995; Connor et al., 1995; Gelman et al., 
1999; Goodman, 1953; Haacke et al., 2005; Hallgren and Sourander, 1958; Koeppen, 1995; Ogg 
and Steen, 1998; Ordidge et al., 1994; Pfefferbaum et al., 2009; Quintana et al., 2006; Schenck 
and Zimmerman, 2004; Schenker et al., 1993; Siemonsen et al., 2008; Stankiewicz et al., 2007; 
Vymazal et al., 1996; Xu et al., 2008; Zaleski, 1886). The importance of iron homeostasis in the 
brain is due to its major role in several biological processes such as normal brain metabolism, 
cell division, mitochondrial function, oxygen transport, neurotransmitter synthesis, electron 
transfer and myelin production (Quintana et al., 2006; Stankiewicz et al., 2007). However, it is 
believed that any deviation from homeostasis of iron can cause neurotoxicity leading to a 
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spectrum of neuropathological outcomes (Quintana et al., 2006; Schenck and Zimmerman, 2004; 
Stankiewicz et al., 2007). To avoid this issue, living organisms have developed systems to store 
this excess of iron and work as a buffer against iron overload and deficiency (Ropele et al., 
2011).  
The normal adult human body contains 3 to 5g of iron. Iron is categorized as being either 
heme-iron (found in hemoglobin - in this state, iron plays a major role in oxygen transport) or 
non-heme iron. Non-heme iron can appear in low molecular weight complexes, metalloproteins 
(such as transferrin), ionic iron, as well as ferritin and hemosiderin (molecules that are 
responsible for iron storage) (Haacke et al., 2005). 
 
 
Figure 2.1: The heme cofactor of the protein hemoglobin (Bizzi et al., 1990) 
 
Heme-iron (figure 2.1) contains two thirds of the total iron in the body while the other 
third appears as non heme-iron mostly in the form of ferritin (Hallgren and Sourander, 1958). 
Iron appears to preferentially be in the form of ferric (Fe
3+
) more than in ferrous (Fe
2+
) iron.  
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2.1 Iron types 
Ferritin (molecular weight = 474kg/mol) is mainly a soluble iron storage protein and 
barely involved in metabolic activities. It plays a role in maintaining homeostatic levels of iron in 
the human body. This protein can store up to 4500 iron atoms (figure 2.2). It is composed of 
twenty four subunits consisting of heavy (H-ferritin) and light (L-Ferritin) subunits. Different 
combinations of H and L chains define the physiochemical properties of each ferritin protein. H-
rich ferritin proteins are more efficient in iron sequestration (where iron uptake is dominant, 
given that H-chains take up and release iron more rapidly than L-chains) (Beard et al., 1993). 
Heretofore, H- ferritin is the responsive protein that acts in the early stages of iron accumulation 
whereas L-subunit ferritin plays a role as storage protein in later stages making L-rich ferritin the 
proteins of choice for iron storage (Haacke et al., 2005). H-chains are usually found in neurons 
(oligodendrocytic cells) and L-chains are found in glial cells (macrophages and microglia) 
(Connor and Menzies, 1995; Connor et al., 1995). Moreover, H-ferritin is dominant in organs 
that require iron detoxification such as the heart and the brain since its physiological task is to 
protect cells from the redox active Fe
2+
. That is why it accumulates almost 90% of non-heme 
  
iron  
Figure 2.2: Ferritin molecules store thousands of iron atoms within their mineral core. (cdc.gov) 
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iron in order to provide a cellular protection through its H-subunit. On the other hand, L-subunits 
are responsible for the facilitation of mineralization (Connor and Menzies, 1995; Connor et al., 
1995). These ferritin proteins increase with age except in the substantia nigra, and the ratio H/L 
decreases with age (Connor and Menzies, 1995; Connor et al., 1995).  
Hemosiderin, the second iron storage protein, is insoluble and is considered to be a 
degradation product of ferritin. Studies have showed that the majority of brain iron in diseased 
brains is in the form of hemosiderin aggregates rather than isolated ferritin molecules (Schenck 
and Zimmerman, 2004). For instance, when an extravasation of blood takes place, the brain 
converts the heme-iron to hemosiderin. This is important when studying subarachnoid 
hemorrhage (Imaizumi et al., 2003), stroke (Kleinig, 2013), cerebral amyloid angiopathy in 
dementia (Chao et al., 2006) and in traumatic brain injury (Benson et al., 2012). 
Transferrin (molecular weight = 79.6kg/mol) – another non-heme iron protein – plays a 
role in delivering the iron to the whole body and the brain across the blood brain barrier (from 
the blood to the brain tissue) via specific receptors located in the microvasculature (Haacke et al., 
2005). The transferrin chain (which is composed of two carbohydrate groups and amino acids) 
can only bind two iron atoms (making transferrin undetectable using magnetic resonance 
imaging). Transferrin, transferrin mRNA and transferrin receptor expression in the normal brain 
are related to oligodendrocytes and myelin formation whereas ferritin is a marker for normal and 
activated microglia in the CNS. 
 
2.2 Iron distribution in the brain 
Iron in the brain is heterogeneously distributed, specifically in the white matter, gray 
matter, and the cerebral cortex (Haacke et al., 2005). Enhancing Perl's staining for visualizing 
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iron in tissue using diaminobenzidine tetrahydrochlride has revealed more histochemical details 
showing iron in many cell types of the CNS such as neurons microglia, oligodendroglia, 
astrocytes and in some myelin sheaths (Koeppen, 1995). Iron and ferritin have been 
histologically reported to be equally distributed in GM and WM, while transferrin seemed to be 
more abundant in WM compared to GM (Connor et al., 1992). In the deep gray matter, the 
structures were found to accumulate ferritin at different rates as a function of age (see next 
section). Total iron values have been found to be highest in the globus pallidus (GP), followed by 
the putamen (PUT), caudate nucleus (CN), thalamus, cortical gray matter and cortical white 
matter as well as in the dentate nucleus (Koeppen, 1995). The distribution of non heme iron is 
found in the motor cortex with highest concentration followed by, decreasingly, the occipital, 
sensory, parietal, prefrontal and temporal cortex (Hallgren and Sourander, 1958). Xu et al. 
showed that the left hemisphere has more iron than the right hemisphere specifically in the PUT, 
GP, substantia nigra (SN), thalamus (THA) and the frontal WM. However, no significant 
difference was found while comparing the results according to gender (Xu et al., 2008). 
 
2.3 Iron and Age 
Another point of interest in studying iron in the brain is the understanding of its 
dependability on age.  Iron levels have been shown to be low in newborn brain and start 
increasing rapidly until the age of 20 to 30 years, where it reaches stable levels (Goodman, 1953; 
Hallgren and Sourander, 1958; Xu et al., 2008; Zivadinov et al., 2010). Iron uptake into the brain 
reaches its maximum during rapid brain growth which concurs the peak of myelinogenesis 
(Beard et al., 1993), and continues throughout life. However, some controversies have been 
reported based on the assessments of specific regions and using different methods (Haacke et al., 
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2010c). In the literature, iron deposition as a function of age has been reported for many 
structures individually (basal ganglia, thalamus and midbrain). For instance, the PUT, pulvinar 
thalamus (PT) and red nucleus (RN) showed increased iron deposition till the 5
th
 decade and 6
th
 
decade, with the highest rate in the first two decades (Hallgren and Sourander, 1958; Zivadinov 
et al., 2010). Same effect was seen in the CN but at a faster rate in the 4
th
 decade. The GP on the 
other hand showed an increase till the 3
rd
 decade to reach a plateau at the age of 30. There was 
no agreement between studies on how does iron behave in the thalamus with age (Zivadinov et 
al., 2010). One study reported no change as a function of age (Xu et al., 2008); another showed 
increase linearly with age (Haacke et al., 2010c), while others showed a similar behavior as the 
GP (Hallgren and Sourander, 1958).  Finally, many studies agreed that iron the SN increases 
rapidly in the first 2 decades of age and reaches a constant value throughout life (Haacke et al., 
2010c). Striatal and brain stem structures have higher iron concentrations in older people 
whereas cortical white matter and thalamus have higher iron concentrations in the younger 
people (Pfefferbaum et al., 2009). This effect has been seen in the RN and SN as well. As can be 
seen from the previous discussion, levels of non-heme iron are not uniform spatially or 
temporally. 
In the next section, we will go over some pathologies where iron abnormalities seem to 
contribute to the etiology of these diseases.  
 
2.4 Iron and Neurodegenerative Disease 
Iron misregulation in the body and specifically in the brain, has long been associated with 
neurodegenerative disease (Sullivan, 2004). The mechanisms of damage linked to iron are 
differently described based on each disease and yet these mechanisms are still debatable (Hare et 
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al., 2013). Some studies reported that oxidative stress might be the triggering factor, while others 
stated that a pathological process leads to iron accumulation and creates a pathophysiological 
loop involving iron (Hammond et al., 2008). Some of these processes have been identified as 
cellular, immunological and others as vascular (Haacke et al., 2012b). The complexity of the iron 
uptake and regulation on a cellular level makes this mechanism susceptible, leading to disruption 
of its normal function and to cellular degradation and pathogenic pathways.  
To emphasize the complexity of this mechanism, the following paragraph will briefly go 
over iron circulation and brain uptake. A more detailed description of these mechanisms can be 
found in the review by Hare el al. (Hare et al., 2013).  
Transferrin is the major iron transporter in the body. It can hold two iron molecules each. 
At a given time, and under normal conditions, only 30% of transferrin proteins are occupied. 
Once in the blood and occupied, Fe2Tf cannot cross the blood brain barrier due to the 
hydrophobic barricade. To cross the blood brain barrier (BBB), Tf binds to Tf receptors, which 
pass through the brain capillary endothelial cells, as an endocytotic mechanism. Another way of 
iron import to the cell is through low molecular weight complexes. Export of iron is regulated by 
ferroportin, which is manipulated by the expression of tau and ceruloplasmin, controlling the 
available iron in the so-called labile iron pool. The latter is regulated by cellular metal sensing 
and iron binding protein expression (such as ferritin), based on the status of iron and the demand 
by the cell. Controlling iron homeostasis doesn’t only happen with iron regulation, but can also 
be manipulated via regulation of iron associated proteins. For instance, Tf export from the cell is 
done through divalent metal transporter-1 (DMT-1). The proper function of DMT-1 will play a 
role in the availability of apo-Tf which in charge of binding to iron and deliver them under iron 
overload or depletion conditions (Hare et al., 2013).  This shows the number of factors involved 
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in iron regulation and therefore, it can be expected that disturbance of iron metabolism can occur 
at several levels: iron uptake and release, storage, intracellular metabolism and regulation 
(Stankiewicz et al., 2007).  
When any of these iron levels are disturbed, neurochemical effects go into play leading to 
perturbation of neurotransmitter signaling and variation in energy and myelin production (Hare 
et al., 2013). These changes lead to a spectrum of pathogenic pathways based on their role in 
maintaining a healthy body. One would expect that changes in the neurotransmitter levels will 
affect motor skills, language, mood and attention. One well-known disorder that manifests in 
hyperactivity, inattention and impulsiveness is attention deficit hyperactivity disorder (ADHD). 
It is believed that the involvement of iron in dopamine neurotransmission might be play a role in 
ADHD if brain iron deficiency occurs (Konofal et al., 2004). In addition, the brain is always in 
high energy demand. Given that mitochondrial enzymes do frequently utilize iron, iron depletion 
might impair their function leading to a decrease in energy production and increase in oxidative 
stress (Walter et al., 2002). On the other hand, when production of myelin is in jeopardy, one 
would expect a series of neurological symptoms due to the decrease integrity of the neurons. 
Although this is still an underexplored subject, iron accumulation and demyelination accompany 
many neurodegenerative diseases, including Parkinson’s disease, Huntington’s Disease and 
Multiple Sclerosis (Quintana, 2007; Stankiewicz et al., 2007).  In the past, abnormal iron 
deposition assessment was only possible postmortem; however, with recent advances in imaging 
techniques, it became possible to not only visualize but also monitor these changes in vivo. These 
techniques are discussed in the next section. 
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2.5 Iron as seen with MRI 
The ability of MRI to create an image of the human body lies behind the fact that its 
signal originates from the protons of the water molecules. In addition, the contrast generated is 
based on the tissue properties of each structure whether via total water content, relaxation times 
or other imaging characteristics. The presence of metals in sufficient amount will alter the 
magnetic properties of the tissue and generate a contrast change (via relaxivity and susceptibility 
effects), making it possible to visualize and quantify them in vivo. However, if other metals also 
exist in the brain but in small concentrations (such as copper, zinc, etc…), their presence will not 
affect the quantification of iron given that their effects on the local magnetic field is negligible. 
There has been considerable interest in normal brain iron quantification as well as in 
neurodegenerative diseases in order to understand their pathogenesis, monitor their progress and 
establish neuro-protective treatments (Hagemeier et al., 2013; Langkammer et al., 2013; Lim et 
al., 2013; Muhoberac and Vidal, 2013; Yang et al., 2013). Developing and improving MRI has 
been an important task for decades, trying to establish a correlation between the observed signal 
and iron concentration. Ferritin and hemosiderin are the two major molecules that are considered 
to be the only forms of non-heme iron present in sufficient quantities to affect MR contrast in the 
brain (Haacke et al., 2005). On the other hand, iron related proteins such as transferrin, 
transferrin receptor and the ferritin receptor protein are almost undetectable using MR due to 
their low concentrations.  
Many MR imaging techniques have been used to measure iron in vivo due to the effect of 
iron on signal intensity. As described below, each technique has its advantages as well as its 
drawbacks. While some MRI sequences did not achieve a strong correlation with iron (such as 
T2, for example), many others showed promising results for iron evaluation such as T2′ and T2* 
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quantification (Gelman et al., 1999; Ordidge et al., 1994) as well as Field-Dependent Relaxation 
Rate Increase (FDRI) (Bartzokis et al., 1993), magnetic field correlation (MFC) (Jensen et al., 
2009), and susceptibility weighted imaging (SWI) (Haacke et al., 2010c). 
 
T2, T2* and T2' weighted imaging: 
Relaxation rates (R2, R2* and R2') are reported to increase with an increase in the 
concentration of paramagnetic material (Haacke et al., 2005). Therefore, in the presence of iron, 
darkening or hypointensities are visualized in structures with high iron deposition. In addition, 
T2* and T2 both decrease with increasing magnetic field. The drawback of R2 (also R2* given 
that R2* = R2 + R2'), is its sensitivity to not only iron but also water content, which makes R2 an 
imprecise method to evaluate iron when diseased tissue is imaged. For instance, if a lesion with 
edema is imaged, it has high water content, which will lead to a decrease in R2, and therefore, 
iron content will be underestimated. Therefore, R2' has become a better, more accurate approach 
to image iron, as it takes out the water fraction effect and makes it possible to evaluate the signal 
change due to local susceptibility variations seen in the presence of iron. These measures have 
been reported to better correlate with iron concentration. Although R2 showed more sensitivity 
to GM/WM differentiation then R2′, R2 was not able to present specificity for iron (Ordidge et 
al., 1994). On the other hand, R2′ showed a good correlation with iron load (Schenker et al., 
1993). In another study, T2′ and T2* decreased in GM but increased in WM in the aging brain 
(Siemonsen et al., 2008). More detailed discussion of these concepts, as used in this thesis, will 
appear in chapter 3. 
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T1 weighted imaging:  
T1 weighted imaging has also been used as a means to investigate iron in the brain. Iron 
can create a dipolar relaxation mechanism, during which water protons sense magnetic field 
fluctuation created by ferritin and water diffusion in its vicinity. This dipolar relaxation has an 
effect on the longitudinal magnetization and, theretofore, a signal increase is seen on T1 
weighted images. Based on this mechanism, T1WI can correlate iron concentrations in the brain 
as seen in postmortem brains (Ogg and Steen, 1998; Vymazal et al., 1996) and shows a good 
linear dependency on iron, but with a lower effect compared to T2. In addition, T1 effect is field 
dependent and falls off at higher field while T2 is field independent (Vymazal et al., 1996). 
 
Phase Imaging:  
Phase is proportional to local magnetic field changes. The latter is proportional to the 
local magnetic susceptibility which is a direct measure of local iron content. Phase has been 
shown to be sensitive to iron and shows a strong correlation as a function of age (Haacke et al., 
2010c). More recently, phase has been used to generate a quantitative susceptibility map (Zheng 
et al., 2013), which also correlates well with iron deposition. This approach takes away the 
dependability of phase on spatial susceptibility distribution and orientation and avoiding many of 
the problems currently faced with phase alone (Schafer et al., 2009). The ability of phase to 
image iron will be described in more detail in the next chapter. 
Several other techniques have been used to image iron in vivo but will not be discussed in 
details here. Of these methods, FDRI (which evaluates the differences in R2 at two different field 
strength), was used by Bartzokis et al. to image iron content and has shown a good agreement 
with iron concentration (ferritin specific) in normal aging (Bartzokis et al., 1993); and MFC 
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Imaging (Jensen et al., 2009) (which is composed of a series of asymmetric spin echo sequences 
giving a T2* like contrast to evaluates microscopic field variations as a means to assess iron 
content).  
Each of these methods mentioned above has its drawbacks, however, some methods will 
always present relative measures (relaxation times and MFC approaches), while others will offer 
(when all confounding factors are eliminated) an absolute quantification approach by directly 
evaluating and mapping magnetic susceptibilities (such as QSM). It is strongly noted that 
although phase and susceptibility effects seen on MR images exhibit a strong contrast between 
white matter and gray matter, this contrast is not solely generated by iron; instead, myelin 
sheaths which are wrapping the neuronal bundles in the WM are diamagnetic, which decreases 
the susceptibility values in the region of interest and underestimates iron contact in these regions 
(Liu et al., 2011). This chapter presented an overview on iron and its role in the human body and 
brain and discussed some pathological consequences when iron deviates from its normal levels. 
We also listed some approaches which are currently in use to evaluate iron content in vivo. In the 
next chapter, we will talk in depth about one of these MR methods, phase imaging, acquired 
using gradient echo acquisition scheme, and which will then be used to evaluate iron content in 
normal controls and MS patients as will be described in chapters 4, 6 and 7. 
17 
 
 
Chapter Three 
SUSCEPTIBILITY WEIGHTED IMAGING 
Chapter overview 
In the past decade, susceptibility weighted imaging (SWI) has received a great deal of 
attention in both the research and clinical realms (Haacke et al., 2009b; Mittal et al., 2009). Due 
to its new source of contrast compared to conventional MRI, SWI presents new directions in 
studying the brain and its vasculature as well as other organs in the body, where magnetic 
materials (source of contrast) seem to play an important role in normal aging and disease states 
of these structures. In this chapter, we will explore the basic concepts of SWI, ranging from basic 
physics, image acquisition to post processing and creation of the magnitude, phase and SW 
images which will be used in later chapters to image the brain and assess iron content in vivo. 
We will emphasize the effect of susceptibility on the MR signal, the gradient echo acquisition 
scheme used in SWI, and how phase will be used to generate the SW image contrast. 
 
Introduction 
 As emphasized in its name, SWI highlights the susceptibility differences between tissues, 
presenting a new type of contrast different from what is seen in spin density, T1 and T2 weighted 
imaging (Haacke and Reichenbach, 2011). The information that underlies this new contrast 
comes from the phase images which prior to the introduction of SWI were disregarded for a long 
time in MR applications. As we will see in the next few sections, phase reflects the sources of 
magnetic material distribution, albeit often in a non-local fashion. The steps used to create SW 
images are shown in figure 3.1 (Haacke and Reichenbach, 2011) , and will be described in detail 
throughout this chapter.  
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Figure 3.1: Steps involved in creating SW Images 
 
In brief, SW images are acquired based on a 3D, fully flow compensated, high resolution 
gradient echo sequence. The 3D high resolution nature of SWI allows for the acquisition of 
thinner slices which reduces the signal loss from background field homogeneities (Haacke et al., 
2009b). To make the phase images useful, a special high pass filter is applied to remove 
unwanted low spatial frequency undulations and aliasing artifacts. This new filtered phase image 
is used to create a phase mask that is then applied onto the magnitude image. The final SW 
image combines both magnitude and phase contrast: the former coming from the T2* effects and 
the latter reflecting susceptibility effects. The details of these steps will be expanded in the 
remaining sections of this chapter. 
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3.1 Magnetic Susceptibility 
 Magnetic susceptibility is defined as the tendency of a substance to become magnetized 
when it is placed within an external static magnetic field (Haacke et al., 1999). Once magnetized, 
an induced magnetic field (M) is seen inside the object and will lead to perturbation in the 
magnetic field outside the object to a different degree based on the object shape, volume, 
magnetization and position. The full expression for the magnetic field inside the material, under 
the influence of the magnetic field (B0), is given by Equation 3.1: 
 
B = µ0 (H+M)        (3.1) 
 
where B is the resultant magnetic field in Tesla (T), H is the magnetic flux in A/m, M is the bulk 
magnetization per unit volume of the substance in A/m, and µ0 is the absolute permeability of 
free space (4π x 10-7) with units of Tm/A. 
M inside the object and the H field are related through the magnetic susceptibility χ:  
 
M = χ H        (3.2) 
 
Therefore, Equation (3.1) can be re-written as: 
 
B = ( ) µ0 M       (3.3) 
 
For linear materials with χ << 1, equation (3.3) can be written as:  
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M = χB/ µ0        (3.4) 
showing the proportionality between the induced magnetization, the main field and the magnetic 
susceptibility (Haacke et al., 2009b). Based on the value of χ, the material can be characterized 
as paramagnetic (χ > 0), diamagnetic (χ < 0) and ferromagnetic (χ>>1). Ferromagnetic materials 
are not reported in biological organisms, however, paramagnetic forms of iron and diamagnetic 
forms of calcium are both found in humans (Haacke and Reichenbach, 2011).   
Based on what we discussed earlier, any object placed within an external magnetic ﬁeld 
gets magnetized (based on its susceptibility) and usually changes the induced magnetic ﬁeld 
within and outside the object (Haacke et al., 1999). These changes have a high dependence on 
the object geometry and its orientation with respect to the main magnetic field. These field 
changes are easily calculated for objects with structural symmetries like a sphere and a cylinder. 
These two geometries are convenient given that blood vessels can be modeled by long cylinders 
and sinuses are modeled by spheres. The derived solutions for these structures implicitly explain 
what we see on phase images when we look at structures like vessels. Following equation 3.4 
and considering that the objects are in vacuum, the field perturbation inside and outside these 
objects are summarized in table 3.1. However, when these objects are embedded in an external 
medium with some finite susceptibility, χ is replaced by Δχ, in addition to other terms related to 
the geometry of the external compartment (Haacke and Reichenbach, 2011). 
From the concepts described above, tissues with different susceptibilities will exhibit 
spatially varying precession frequencies as manifest through the Larmor frequency that is given 
by: 
  
ω = -γ.B        (3.4) 
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where γ is the gyromagnetic ratio of the proton, ω is the precession angular frequency and B is 
the induced magnetic field seen by the proton. How this signal is acquired will be the topic of 
next section. 
 
Table 3.1: Expressions for Field Inside and Outside a Uniform Sphere and an Infinitely Long 
Cylinder (Haacke and Reichenbach, 2011). 
 
In this table, a is the radius of the cylinder or the sphere; θ represents the angle that the long axis 
of the cylinder makes with B0 or the angle that the position vector r of the point of observation 
makes with the main magnetic field B0 for the spherical case; r is the position vector of the point 
of observation and Φ is the polar angle subtended by r on the plane perpendicular to the long axis 
of the cylinder. 
 
3.2 Gradient Echo Imaging 
 In the presence of an external magnetic field (B0), the proton spins tend to align in a 
parallel and anti-parallel fashion along B0, based on their thermal and magnetic energy. Spin 
excess in the direction of the main field leads to a bulk magnetization M (Haacke et al., 1999). In 
order to be able to measure an MR signal, M should be tipped away from the main magnetic 
field direction. A time varying radiofrequency pulse perpendicular to M, corresponding to the 
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precessional frequency of M (known as Larmor frequency – eq. 3.4), is applied to the system. 
Once in the transverse plane, the net magnetization starts precessing along B0, creating a varying 
flux across the receiving coil and generating an electromotive force (emf). The measured emf is 
is referred to as the free induction decay (figure 3.2). This decay is caused by intrinsic 
interactions of the spins (dephasing) and field inhomogeneities (Haacke et al., 1999). The latter 
was addressed historically by the use of the spin echo. The spin echo sequence used a π-pulse to 
invert the phase of these spins and create an echo. However, these sequences take long time, 
limiting the ability to rapidly acquire high resolution MR data. With a modern system, where 
global field inhomogeneity has become less of a problem, and the availability of dependable time 
varying gradients, a more modern concept known as gradient recalled echo (GRE) imaging has 
become routinely used in every clinical MR application (Haacke and Reichenbach, 2011). The 
advantages of GRE relies on the fact that short echo times are possible eliminating a lot of 
artifacts from the T2* signal decay. In addition, the use of high bandwidth decreases the 
distortion.  
GRE imaging uses large and fast switching gradients to dephase and rephase the MR 
signal in order to create an echo or multiple echoes based on the application (Haacke et al., 
2009b). Figure 3.3 represented an example of a 1D gradient echo showing the dephasing, the 
rephasing and the echo. In the figure on the left, the gradient is dephasing the spins between t1 
and t2. In the figure on the right, the spins are rephased when the polarity of the gradient has 
switched, creating an echo at time t = t4 – (t4-t3)/2 (Haacke et al., 1999). When the spins are 
refocused in the MR signal, only the dephasing created by the gradients is reversed and not the 
phase shifts from the field inhomogeneities, tissue susceptibilities and the chemical shift fields. 
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Some of these effects will be dealt with later by the application of special filters (high pass filter: 
see section 3.4). 
 
Figure 3.2: a) Free induction decay in the laboratory frame. b) the free induction decay signal in 
the rotating frame.  
 
Understanding the effect of imaging parameters on gradient echo sequences is very 
important. For instance, in order to collect a 2D or 3D dataset, the diagram shown in figure 3.3 
should be repeated many times (Frahm et al., 1986). The repetition time (TR) will now play an 
important role in manipulating the available signal. Therefore, it is critical to understand how TR 
affects the available magnetization at each repetition time in both the longitudinal and transverse 
planes. In the cases were TR is much longer than T2 relaxation, transverse magnetization tend to 
vanish prior to the next rf pulse. However, when TR is shorter than T2, transverse magnetization 
is still available and needs to be removed prior to the next acquisition. On the other hand, 
longitudinal magnetization availability is affected by TR and the flip angle (FA). The right 
combination of TR and FA will be required to get the best contrast and signal to noise in the 
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image (Haacke and Reichenbach, 2011). To get a better flavor of this concept, we will introduce 
the concept of steady state gradient echo imaging.  
  
Figure 3.3: 1D gradient Echo experiment. 
 
 The repetition of the rf pulse prior to data collection is needed to reach magnetization 
equilibrium. This will depend on the FA used for that case. For large flip angles, the equilibrium 
is reached with only few rf pulses compared to several hundred rf pulse with low flip angles 
(Frahm et al., 1986; Frahm J, 1986). The equilibrium longitudinal magnetization is given by 
equation 3.5: 
 
Mze = M0. (1-e
-TR/T1
)/(1-cosα.e-TR/T1)     (3.5) 
 
A clear dependence on both FA and TR is seen in equation 3.5. The transverse equilibrium 
magnetization based on eq. (3.5) is given by: 
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ρm(α) = M﬩ = M0. (1-e
-TR/T1
)/(1-cosα.e-TR/T1). sinα. e-TE/T2*               (3.6) 
 
Taking the derivative of eq. (3.6), one can show that the maximum signal occurs at the Ernst 
angle αE
 
with: 
αE = cos
-1
 (e
-TR/T1
)       (3.7) 
 
where αE =   
when TR<<T1 (Haacke et al., 1999). 
Equation 3.6 can tell us a little more about how changing the parameters affect the image 
contrast. For instance, at low flip angles, the image becomes dominated by spin density contrast 
for TE much smaller than T2*. On the other hand, T1 weighted imaging is achieved when a large 
flip angle is selected.  
 
The acquired MR signal is a complex signal which can be represented by a magnitude and phase 
(Haacke et al., 2009b): 
 
Sxy(t) = |Sxy(0)| e
iφ(r, t)
       (3.8) 
 
The MR scanner hardware is used to demodulate the signal into real (Sx(t)) and imaginary (Sy(t)) 
channels. The final images usually output on the scanner are the magnitude of the complex signal 
|Sxy(t)| and the phase image (equal to tan
-1
 (Sy/Sx)) (Haacke et al., 1999). This phase is dependent 
on the position of the spin and the time. Therefore, phase is represented as: 
 
26 
 
 
φ (r, t) = -ω0.t + γ(B(r))t = -γΔBt (with ΔB = gΔχB0)   (3.9) 
 
B(r) shown in eq. (3.9) includes the susceptibility information in addition to field variations due 
to chemical shifts and global geometry. As shown in the spherical and cylindrical cases, field 
variation can occur not only locally inside the object but also external to the object as well. These 
field variations were the main reason why the phase images were usually disregarded in the past. 
Finally, adding the phase component to eq. (3.6) yields: 
 
ρ(α) = ρm(α) e
-iγΔBTE
       (3.10) 
 
Now that we have explained the concept of gradient echo imaging, we will move forward 
to a more detailed description of how this imaging approach is applied to acquire SW images.  
 
3.3 Susceptibility Weighted Imaging 
 SWI is a 3D, fully flow compensated, rf spoiled gradient echo sequence (figure 3.4) 
(Haacke and Reichenbach, 2011) . The terminologies mentioned herein will be described one at a 
time. 3D sequences are generally used to allow a higher resolution imaging in plane and through 
plane (better definition independent of the rf pulse). In some cases, the signal to noise of the 
dataset acquired is higher compared to 2D. 3D imaging is achieved by exciting a slab to cover 
the area of interest and then the data is spatially resolved in the 3D volume by applying partition, 
phase and frequency encoding. In addition, flow is compensated in all three directions (Haacke et 
al., 1999). The reason we are interested in applying flow compensation apart from avoiding 
motion artifacts is our interest in the phase that results from local susceptibility.  
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Figure 3.4: Original sequence diagram for SWI with flow compensation. 
 
For uncompensated sequences, the presence of flow in the vasculature of the brain along the 
bipolar dephasing/rephasing gradient direction leads to an additional accumulation of phase to 
what was shown in eq. (3.8) (Haacke et al., 1999). A spin moving with a constant velocity v 
along the read gradient will have phase of: 
 
φ = γGxvτ
2
        (3.10) 
 
Therefore, using a first order gradient moment nulling in the read and slice select 
direction and applying appropriate velocity compensating gradient waveforms in the phase and 
partition encoding gradients will lead to a full flow compensation, by removing all the 
accumulated phase from flow at echo time in addition to removing all the pulsatility effects 
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caused by variable phases across the cardiac cycle. On the other hand, signal variations caused 
by varying inflow, can only be removed by using low flip angles which reduce T1 dependence 
on the signal. Given the short TR used in SWI, transverse magnetization is usually still available 
prior to the second rf pulse. Therefore, gradient and rf spoiling methods are applied in every 
repetition to ensure no remnant magnetization is found in the transverse plane (Haacke and 
Reichenbach, 2011). The former is achieved by including variable gradients between rf pulses 
(after data acquisition) while the latter is achieved by varying the phase of the rf pulse (usually 
117 degrees) as a function of the rf number. Resultant magnitude and phase images are shown in 
figure 3.5 below. 
 
 
 
 
 
 
 
 
 
Figure 3.5: SWI magnitude and phase images acquired at 4T with a TR/TE/FA of 35/25/15. 
 
3.4 SWI filtered Phase Images (Homodyne High Pass filter) 
The images in figure 3.5 show beautiful contrast between different structures of the brain, 
however, the phase image on the right is confounded by unwanted artifacts resulting from low 
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spatial frequency components of the background field (ΔBglobal geometry + ΔBmain field) (Haacke et 
al., 2009b). To make this image more useful, a high pass filter is applied. This high pass filter is 
created by using an n x n low pass filter divided into the original phase image. This is 
mathematically represented by equation 3.11 below: 
 
ρ' (r) = ρ (r)/ ρn (r)       (3.11) 
 
where ρn (r) represents the truncated n x n complex image.  
This filter size can vary from as little as 16 x 16 for a 512 x 512 original image, to 96 x 
96. However, it should be noted that choosing too large a high filter size can remove useful 
information from large structures, decreasing their contrast and adding an error in quantification 
studies based on phase images. Studies have shown that a 64x64 filter size does a good job 
removing low spatial frequency components while maintaining useful information in the phase 
data (Haacke et al., 2007). An example showing the effect of different filter size is shown in 
figure 3.6.  
As mentioned earlier, this approach presents in a single image the susceptibility contrast 
from the phase images and the signal intensity contrast (based on T2*) from the magnitude 
images. This is accomplished by creating a binary mask from the phase images, which 
suppresses phase of certain values. 
For instance, when the negative phase is of interest, the binary mask sets all the phase 
values at point x, which are positive to 1, and emphasizes the negative values (Haacke et al., 
2009b). This negative mask is given mathematically in equation (3.12): 
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f(x) =  [π + φ (x)]/π   for –π< φ (x) <+π          (3.12) 
  1    otherwise; 
 
  
 
 
 
 
Figure 3.6: Applying a high pass filter of different sizes. From the left, 16x16, 32x32, 64x64 and 
96x96 respectively.  
 
This mask can be applied more than once. It has been shown that applying this mask four times 
fits best for all phase values in the image (Haacke et al., 2009b). An example of SWI images is 
shown in figure 3.7. This is an MS patient imaged at 4T. The SWI image is mipped over 8 slices 
to better enhance the vessel connectivity between slices, presenting a new contrast that is not 
seen in either magnitude or phase images alone. 
 The link between the susceptibility of a material and the final MR image has been 
carefully tailored throughout the chapter. The discussion has shown that the presence of 
magnetically susceptible material such as iron for instance, can be visualized and "relatively" 
measured by phase shifts in the MR signal. The SWI acquisition and processing scheme tries to 
reduce the effect of other phase contributors (flow compensation, high pass filter, short TE and 
TR, low flip angle), to make sure that what we measure is reliable. In the next chapters, we will 
use the phase images to assess iron content in the brain. The word "relatively" which was 
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emphasized before informs the reader that an absolute quantification of iron derived from phase 
is not robust yet due to many contributing factors in the imaging method itself and the imaged 
object (Haacke et al., 2009b).    
 
 
 
 
 
 
 
Figure 3.7: Magnitude, phase and SWI images (mipped over 8 slices) showing sclerotic white 
matter lesions (red arrows), created from the 3D GRE sequence described in this chapter. 
     
In the next chapter, we will assess the contrast to noise ratio and the signal to noise ratio 
of the SWI images compared to conventional MRI, and test its ability to image the midbrain and 
resolve its different structures and substructures. 
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Chapter Four 
CHARACTERIZING THE MESENCEPHALON USING 
SUSCEPTIBILITY WEIGHTED IMAGING 
Introduction 
In recent years, imaging of neurodegenerative disorders like Alzheimer’s, Parkinson’s 
and Huntington’s disease have attracted much attention. Most of these diseases’ pathological 
landmarks have been found in parts of the brainstem, especially in the mesencephalon. The 
substantia nigra, which is the primary source of dopamine synthesis and whose pathways are 
known to involve iron (Sofic et al., 1991) is affected in a number of diseases. Its atrophy and/or 
altered functionality could lead to a disruption of dopamine balance in the brain and may lead to 
motor and/or cognitive deficits. Two other structures involved in coordinating motor function are 
the crus cerebri (located lateral to the substantia nigra) and the red nucleus, which has 
connections to the cerebellum and the spinal cord via a number of key motor tracts. The 
progression of Alzheimer’s, Parkinson’s and Huntington’s diseases has been thought to be 
associated with an increase in iron content in the red nucleus and substantia nigra (Sohmiya et 
al., 2004). Therefore, the ability to differentiate among mesencephalic structures should be 
helpful in visualizing specific damage to these structures and establishing better diagnoses for 
neurodegenerative diseases (Kim et al., 2007; Semnic et al., 2005; Sofic et al., 1991; Sohmiya et 
al., 2001; Sohmiya et al., 2004). 
To date, T1-, T2- and T2*-weighted magnetic resonance imaging (MRI) methods have 
been used to image the mesencephalon (Gelman et al., 1999). Generally, the workhorse in 
anatomical measurements has been 3D T1-weighted gradient-echo imaging. This approach is 
often done with a magnetization-prepared, rapid acquisition gradient-echo (MP RAGE) approach 
that uses an inversion pulse followed by the slice encoding gradients and then loops over the 
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phase encoding gradients (Mugler and Brookeman, 1990). Alongside MP RAGE, a short-TR, 
low flip angle, gradient-echo fast low-angle shot (FLASH) sequence with radiofrequency 
spoiling can be used for T1 contrast (Frahm J, 1986). As an example of applied research in 
imaging the mesencephalon, Shibata, et al. (Sasaki et al., 2006) used T1-weighted imaging to 
investigate changes in neuromelanin levels in the lower tegmentum. Unfortunately, such T1-
based sequences provide rather poor information about upper mesencephalic structures where 
high vascularization is present (Sofic et al., 1991) and where accurate differentiation between 
gray matter structures is needed. T2 imaging shows the substantia nigra and the red nucleus quite 
well but does not distinguish between their substructures (such as the pars reticulata and pars 
compacta of the substatia nigra, or the capsule and interior structures of the red nucleus). Today, 
at 3T and 4T, resolution can be pushed easily to 0.5 mm x 0.5 mm x 2 mm. This level of 
resolution should allow for good 3D imaging of the mesencephalon given that the structures of 
interest are only about 1 cm thick and require thin slices to be evaluated in detail. 
Recently, a method called susceptibility weighted imaging (SWI) has been developed to 
enhance contrast in T2*-weighted imaging (Haacke et al., 2004; Reichenbach et al., 1997). It is 
acquired using a fully flow-compensated gradient-echo imaging method in order to pick up extra 
information from local susceptibility variations in tissue via the phase image (in the past, phase 
was usually discarded as not being useful clinically). Due to the fact that the phase signal is 
sensitive to local field change effects, phase data are used as a new source of contrast. When the 
MR data are collected, there are both real and imaginary components. These are then rearranged 
to create magnitude and phase images. The phase images contain information about local static 
field variations, geometry-induced field variations and the local tissue susceptibility of interest 
here. The first two components tend to have low spatial frequency and can be mostly eliminated 
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by applying a high pass filter. The resulting high pass filtered phase images can be considered to 
be a reasonable representation of the local tissue susceptibility (Haacke et al., 2007). 
Susceptibility changes can be caused by deoxygenated blood (due to the paramagnetic nature of 
deoxyhemoglobin), brain iron (in the form of ferritin or hemosiderin proteins), or calcium (which 
is diamagnetic). The SWI filtered phase images are themselves of anatomic interest and can be 
used to measure the putative non-heme iron content in the basal ganglia and in other areas of the 
brain (Haacke et al., 2007). The SWI filtered phase images can also be modified to produce a 
phase mask that is then multiplied into the magnitude images to create a set of SWI magnitude 
images (Haacke et al., 2004; Reichenbach et al., 1997). These new images now carry unique 
information from the phase and provide improved contrast between veins, arteries and 
surrounding tissue. 
Although SWI has been used to show individual images of the mesencephalon previously 
(Abduljalil et al., 2003; Chakeres et al., 2002; Haacke et al., 2007; Haacke et al., 2004; Rauscher 
et al., 2005), no one has yet performed a systematic and quantitative analysis of the contrast 
between the different structures of the midbrain. In the present work, we quantify contrast 
between and within structures in the human mesencephalon at 1.5T and 4T using SWI. 
Specifically, the following structures will be shown on SWI filtered phase images: the red 
nucleus and its various vascular subcomponents, the capsule of the red nucleus, the substantia 
nigra pars compacta, the substantia nigra pars reticulata, the crus cerebri, the medial geniculate 
body, the sub-thalamic nucleus, the lateral geniculate body and the fascicula nigrale (pallidal-
nigral pathway). The contrast of these structures, provided by SWI filtered phase images, will be 
shown to correlate with the contrast defined by the vascular content in the mesencephalon, 
highlighted by the India ink staining of cadaver brains in Duvernoy’s work (Duvernoy, 1999). 
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High-resolution examples covering the entire mesencephalon (5 slices, each 2 mm thick) will be 
shown at both 1.5T and 4T. 
 
Materials and Methods 
Five volunteers (23 to 27 years old for SWI; 36 to 56 years old for T1 and T2) were 
imaged at 1.5T (Siemens Sonata, Erlangen, Germany) and another five volunteers (23 to 27 
years old for SWI; 29 to 45 years old for T1 and T2) were imaged at 4.0T (Bruker/Siemens 
Medspec, Ettlingen, Germany). Institutional review board approval was obtained and all 
participants signed the appropriate consent forms. All images were collected in a predominantly 
axial orientation following the AC/PC line. Detailed imaging protocols are given below. 
 
1.5T imaging protocol 
A segmented echo-planar imaging sequence (5 echoes) was used for the SWI scans. The 
sequence was collected with a resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices, TR = 71 ms, 
TE = 40 ms, BW = 130 Hz/pixel, FA = 20°, a matrix size of 512x512, and an acquisition time of 
8 minutes, 57 seconds. The conventional 3D T1-weighted images were collected with a 
resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices (with a parallel imaging factor of 2), TR = 
20 ms, TE = 5.58 ms, BW = 130 Hz/pixel, FA = 25
o
, a matrix size of 512x512, and an 
acquisition time of 4 minutes, 11 seconds. The T2 data were collected with a resolution of 0.5 
mm by 0.5 mm by 4 mm, 25 slices, TR = 5230 ms, TE = 106 ms, FA = 160
 o
, BW = 130 
Hz/pixel, a matrix size of 512x384, and an acquisition time of 4 minutes, 47 seconds. 
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4T imaging protocol 
A fully flow-compensated gradient-echo sequence was used with parallel imaging (for a 
factor-of-two drop in acquisition time) for the SWI scans. The sequence was collected with a 
resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices, TR = 24 ms, TE = 15ms, BW = 80 
Hz/pixel, and FA = 12
o
, a matrix size of 512x512, and an acquisition time of 12 minutes, 52 
seconds. The 3D T1-weighted images were collected with a resolution of 0.5 mm by 0.5 mm by 
2 mm, 64 slices (with a parallel imaging factor of 2), TR = 20 ms, TE = 5.58 ms, BW = 130 
Hz/pixel and FA = 25
o
, a matrix size of 512 x 512, and an acquisition time of 4 minutes, 47 
seconds. The T2 data were collected with a resolution of 0.8 mm by 0.8 mm by 3 mm, 36 slices, 
TR = 4950 ms, TE = 72 ms, FA = 150
o
, BW = 120 Hz/pixel, a matrix size of 320x240 and an 
acquisition time of 4 minutes, 53 seconds. 
 
Evaluating the SWI data 
The data were processed with in-house Visual C++-based software called SPIN (Signal 
Processing In NMR). SWI data were processed using a 64 x 64 high-pass filter to create a 
filtered phase image. Window level adjustments were made to view the best image contrast. In 
measuring contrast, the signal for a given structure was measured from a 100-200 pixel region of 
interest (ROI) drawn within the structure of interest. For all sequences, contrast-to-noise ratios 
(CNRs) were calculated between a variety of structures as the signal difference between two 
structures (Sa, Sb), divided by the noise (σ), or (Sa – Sb)/σ. The noise was calculated as 0.8 times 
the mean of a 100-200 pixel ROI outside of the head and away from phase encoding artifacts (a 
region where only noise was present). Since the structures measured are bilateral, the CNR for a 
given structure was measured from the ROI having the best apparent contrast. Where the 
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appropriate contrast was visible, we calculated the CNR between: (1) the red nucleus and the 
intermediate area (separating the red nucleus from the substantia nigra); (2) the red nucleus and 
its capsule; (3) the capsule of the red nucleus and the intermediate area; (4) the substantia nigra 
and the intermediate area; (5) the substantia nigra and the crus cerebri; (6) the substantia nigra 
pars compacta and the substantia nigra pars reticulata; (7) the substantia nigra pars compacta and 
the intermediate area; (8) the substantia nigra pars reticulata and the crus cerebri; (9) the lateral 
and central aspects of the medial geniculate body; and (10) the central aspect of the medial 
geniculate body and the intermediate area. Background noise was also evaluated outside the 
image and compared with the standard deviation seen inside the ROI. Each subject data set was 
carefully scrutinized to find the five or six slices associated with the mesencephalic structures of 
interest. The MR results were compared to the measurements of mesencephalic capillary density 
in cadaver brains by Duvernoy, who (using 3-mm-thick slices) performed India ink staining and 
5% gelatin injections to highlight anatomical differences. 
 
Results 
The area reviewed in the mesencephalon is shown in figure 4.1. A comparison between 
T1, T2 and SWI contrast, alongside Duvernoy’s India ink-stained results, is shown in figure 4.2.  
Overall, there is little contrast in the T1 images, while the T2 images show good contrast 
for the red nucleus and substantia nigra. The SWI images, however, show good contrast with 
details of the internal structures visible for the red nucleus, the substantia nigra, the crus cerebri 
and the medial geniculate body (figure 4.3). On the SWI filtered phase images, we see the red 
nucleus broken up into a highly vascularized portion and a less-vascularized portion. The images 
from Duvernoy show the horseshoe effect of the vascularized red nucleus, and this is well-
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mimicked in the SWI results (figure 4.4C, D: arrow 4.4a). Also, the connecting tissue from the 
substantia nigra is seen to course laterally through the crus cerebri (figure 4.4C, D: arrow 1). The 
substantia nigra can occasionally be seen as having two parts: the pars reticulata (the lateral 
portion, containing more iron; figure 4.4: arrow 2a) and the pars compacta (the medial portion, 
containing slightly less iron; figure 4.4: arrow 2b). Similar to the behavior seen in the red 
nucleus, the dark, more vascularized region in the lateral aspect of the medial geniculate body is 
visualized in SWI (figure 4.4: arrow 6). Finally, the pallidal-nigral pathway (the fascicula 
nigrale)—which may transport iron between the substantia nigra and globus pallidus—is also 
seen (figure 4.4B-D: arrow 5). Much of these structures’ anatomy changes with each 2 mm-thick 
slice and many details would not be visible with thicker slices. 
In terms of capillary density, the patterns shown in Duvernoy’s work appear to be 
duplicated in the SWI phase images. In addition to the differentiation displayed within the 
substantia nigra, the red nucleus is seen to contain two regions: a highly vascularized horseshoe 
area and a brighter central region (figure 4.4C, D: arrows 4.4a, b). In general, the local decrease 
in phase correlates with the darkened patterns of vascularization in Duvernoy’s work. 
In terms of quantitative tissue differentiation, we have found that SWI provides good 
contrast, especially when considering all components of the mesencephalon. CNR results are 
provided in Table 4.1 for 1.5T and Table 4.2 for 4T. The effect of improved SNR at high field 
and reduced T2 is evident in the images themselves wherever iron content is high. In SWI, the 
CNR generally increases from 1.5T to 4T, but this increase is dependent on the structure of 
interest. In some cases (in the medial geniculate body, for example) the CNR increases by a 
factor of three from 1.5T to 4T. In other cases, there is only a 25% increase in CNR (in the red 
nucleus, for example).  
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Figure 4.1: A-F, The midbrain as a region-of-interest on 4T SWI magnitude images shown in 
sagittal and coronal sections, with and without slice locators. Arrows 1, 2 and 3 point to the red 
nucleus, the subthalamic nucleus and the substantia nigra, respectively. 
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Figure 4.2: A comparison of one region of the mesencephalon for different sequences and field 
strengths with Duvernoy's stained cadaver brain results. A, T1 at 1.5T; B, T1 at 4T; C, T2 at 
1.5T; D, T2 at 4T; E, Duvernoy's India ink-stained image; F, SWI magnitude at 1.5T; G, SWI 
high-pass filtered phase at 1.5T; H, SWI magnitude at 4T; I, SWI high-pass filtered phase at 4T; 
J, Duvernoy's India ink-stained image. (Images (E) and (J) obtained with kind permission of 
Springer Science and Business Media.) 
 
Figure 4.3: A comparison between adjacent slices in SWI magnitude and high-pass filtered 
phase images at 1.5T and 4T with Duvernoy's India ink-stained results. A, Magnitude SWI at 
1.5T; B, High-pass filtered phase at 1.5T; C, Magnitude SWI at 4T; D, High-pass filtered phase 
at 4T; E, Duvernoy's results. Only three unique images from Duvernoy are shown here since his 
slice thickness is 3 mm. The third and fourth images from the top are identical. (Images in 
column (E) obtained with kind permission of Springer Science and Business Media.) 
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Figure 4.4: A comparison of SWI high-pass filtered phase images (B and D) with Duvernoy's 
India ink-stained results (A and C). Anterior (A and B) and posterior (C and D) mesencephalic 
structures are indicated. 1: crus cerebri; 2a: substantia nigra, pars reticulata; 2b: substantia nigra, 
pars compacta; 3: capsule of the red nucleus; 4a: red nucleus (vascularized region); 4b: red 
nucleus (non-vascularized region); 5: fascicula nigrale; 6: medial geniculate body; 7: superior 
colliculus. (Images (A) and (C) obtained with kind permission of Springer Science and Business 
Media.) 
 
 
 
 
 
 
 
 
 
42 
 
 
Table 4.1: 1.5T Contrast-to-Noise Ratio (CNR) measurements. The first row for each sequence 
represents the mean in a given region-of-interest (ROI), while the second row represents the 
standard deviation (SD) in the same ROI. (No contrast for the given ROIs was observed in the 
gradient echo T1 data.)  
 
Sequence Red Nucleus CNR Substantia Nigra CNR Medial Geniculate CNR 
 IA/RN IA/RN 
capsule 
RN/RN 
capsule 
IA/SNc CC/SNr SNc/SNr CMG/LMG CMG/IA 
T2 tse 4.13 — — 6.19* 4.97* — — — 
T2 tse SD 1.23 — — 1.44* 1.48* — — — 
SWI — 1.43 4.54 5.58 2.84 3.74 1.38 0.45 
SWI SD — 0.73 1.62 0.6 0.75 1.46 1.47 0.35 
 
 
Table 4.2: 4T Contrast-to-Noise Ratio (CNR) measurements. The first row for each sequence 
represents the mean in a given region-of-interest (ROI), while the second row represents the 
standard deviation (SD) in the same ROI. (No contrast for the given ROIs was observed in the 
gradient echo T1 data.)  
Sequence Red Nucleus CNR Substantia Nigra CNR Medial Geniculate CNR 
  IA/R
N 
IA/RN 
capsule 
RN/RN 
capsule 
IA/SNc CC/SNr SNc/SNr CMG/LMG CMG/IA 
T2 tse 3.36 — — 4.53* 6.27* — — — 
T2 tse SD 0.77 — — 0.48* 1.64* — — — 
SWI — 1.13 5.85 8.75 5.19 3.56 4.57 1.64 
SWI SD — 1.34 2.23 1.67 1.51 1.08 2.49 0.89 
 
RN: red nucleus; SNc: substantia nigra, pars compacta; SNr: substantia nigra, pars reticulata; IA: 
intermediate area between RN and SN; CC: crus cerebri; LMG: lateral aspect of the medial 
geniculate body; CMG: central aspect of medial geniculate body. Empty data boxes show that 
CNR between certain structures could not be calculated because the structures could not be 
detected. 
* Since SNc and SNr were not seen for T2, CNR is recorded here for IA/SN and CC/SN. 
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Discussion 
Iron plays a key role in many neurological processes. It is of great interest in the study of 
neurodegenerative disease today and iron remains a topic of high interest in the medical 
community. SWI offers a way to look at iron content that is different from T1, T2 or T2* maps. 
The SWI filtered phase images are a sensitive means to not only visualize the presence of iron 
but also to quantify it (Haacke et al., 2007; Haacke et al., 2005; Ogg et al., 1999). The non-heme 
forms of iron that are likely seen with MR are ferritin and hemosiderin. Ferritin appears to be 
seen predominantly in the basal ganglia and primary motor cortex. Gray matter has more ferritin 
than white matter, although there are indications that ferritin is also present in white matter 
(Haacke et al., 2007). Iron in transferrin or in glial cells may be non-magnetic and therefore 
invisible to MR imaging. This may explain why white matter appears to have less iron than gray 
matter on MRI, while staining reveals the opposite (Haacke et al., 2005). 
Based on the data collected at 1.5T and 4T, we can see that highly vascularized areas, 
like the vascularized region of the red nucleus (as specified in Duvernoy’s work), become more 
prominent or darker on SWI filtered phase images at higher field (figures 4.2, 4.3). Thus, the 
contrast between the red nucleus and the surrounding brain tissue improves with increasing field 
strength. In fact, we are able to see the capsule of the red nucleus at 4T in the magnitude images 
for the first time (figures 4.2H, 4.3C). (SWI filtered phase images can visualize the capsule at 
1.5T, but the magnitude images do not). Although the CNR is often large than 4:1 (the CNR 
needed to be able to visualize clearly one structure from another) this was not always the case. 
Further, the T2 images had thicker slices and hence their CNR is overestimated by the ratio of 
their thicknesses compared to the 2mm used in the SWI scans. Further, the CNR at 4T is even 
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further overestimated by a factor of 1.6 because of the lower resolution of 0.8mm compared to 
0.5mm with the SWI scan.  
Hypothetically, if we are able to prove that iron causes a reduction in T2 or T2* with 
increasing magnetic field strength, we would be able to predict that the areas with the higher 
capillary density would appear darker at high field. An interesting study would be to investigate 
the relationship between iron and vascular density. E. Sofic (Sofic et al., 1991) and C. M. Morris 
(Morris et al., 1992) showed that large ferritin deposits are associated with the small blood 
vessels of the basal ganglia. The strong correspondence of SWI phase and high-field magnitude 
images with Duvernoy’s India ink-stained images (Duvernoy, 1999) and Morris, et al.’s results 
(Morris et al., 1992) therefore suggests that the non-heme iron visualized in MRI in normal brain 
is most likely due to ferritin associated with the vascular network. If this hypothesis is verified, 
these SWI magnitude and filtered phase images may prove to be an important means by which to 
understand microvascular effects in neurodegenerative diseases. 
In conclusion, the high iron content in the red nucleus and substantia nigra leads to a 
susceptibility change in the tissue that causes a reduction of the phase in these regions in the SWI 
filtered phase images. This phase change can be used either by itself or to create a magnitude 
susceptibility weighted image. In either case, this property leads to improved contrast in the 
mesencephalon using SWI. The improved contrast in the phase images may provide a means by 
which to monitor changes in the mesencephalon with age or disease state. 
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Chapter Five 
MULTIPLE SCLEROSIS 
Chapter overview 
 Chapter 2 covered the importance of iron in the human body and brain and the potential 
consequences of free iron deposition being toxic and leading to the development of 
neurodegenerative diseases. In this chapter, we will present a broad overview of one such 
disease, multiple sclerosis (MS). The definition of MS, its types as well as its clinical 
manifestations, will be discussed. The main areas of ongoing research into MS pathogenesis will 
be emphasized including the immunological, cellular, molecular, neuronal as well as vascular 
involvement. 
 
Introduction 
MS is widely accepted as an autoimmune, inflammatory, demyelinating disease of the 
central nervous system (CNS) (Noseworthy et al., 2000b). This pathology is recognized as the 
most common cause of progressive neurologic disability in young adults worldwide. What 
initiates the disease and the sequence of events underlying the development of MS is not yet 
well-established (Noseworthy et al., 2000b). However, technological progress as well as the 
outcomes of successful research has been able to shed some important insights on most factors 
involved in the pathology of this complex disease. For instance, although there is no precise 
description or understanding of the nature of this disease, a lot of work has already been done to 
provide a reasonable clinical, immunological, neurological and vascular understanding of the 
disease.  
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Multiple Sclerosis: Clinical Landmarks 
5.1 – Different types of MS 
5.1.1 Definitions 
For a long time, four main clinical phenomena have been recognized as expressed in the 
course of multiple sclerosis: initial attack, remission, relapse and progression (Confavreux and 
Vukusic, 2008). Clinically, relapses, also known as exacerbations or attacks, are usually 
associated with focal inflammation of acute lesions or reactivation of older lesions. These attacks 
usually end with a remission which can be either partial or complete. The duration of these 
exacerbations is usually more than 24 hours although 48 hours is the minimum required duration 
to be considered as attacks (Poser et al., 1983). The emergence of fatigue alone is not enough to 
be considered a relapse. The fourth phenomenon, progression, is defined as the steady increase in 
symptoms and signs for more than 6 months (Poser et al., 1983). In other words, progression is 
the clinical manifestation of chronic, progressive, diffuse degeneration of the CNS.  
The occurrence of these relapses and progression defines two distinct phases in the 
course of MS: the relapsing-remitting (RR) phase, which is characterized by alternating relapses 
with episodes of clinical inactivity, and the progressive phase which occurs after consecutive 
relapses and remissions. In some circumstances, steadily progressive course can be reached right 
from clinical onset. To summarize: 
1. Relapsing-remitting (RR) MS is characterized by well-defined relapses with full remissions or 
with some deficits on recovery.  
2. Secondary progressive (SP) MS starts with a relapsing-remitting disease course and 
progresses with some chances of minor remissions, occasional relapses and sometimes plateaus. 
47 
 
 
3. Primary progressive (PP) MS is characterized by disease progression from initial clinical 
onset with some temporary improvements and occasional plateaus.  
4. Progressive-relapsing (PR) MS is characterized by progressive disease from the beginning of 
clinical symptoms, with clearly defined relapses, and continuing progression between relapsing 
periods. 
Although it is still under review by MS experts, clinically isolated syndrome is defined 
for individuals who have a first neurological (monofocal or multifocal) episode lasting 24 hours 
or more as a result of inflammation in the CNS. Monofocal episode might be limited to an optic 
neuritis attack, while multifocal episode might reveal weakness on one side in addition to optic 
neuritis for example. CIS is considered an early sign exhibited by those individuals that might 
develop one of the MS types mentioned above. However, if caught at that stage, these 
individuals can be treated early to avoid or delay the onset of clinically definite MS. 
 
5.1.2 Comparison between MS types 
At first glance, relapses appear to be the major player in MS pathology. Furthermore, 
many relapse-related factors are associated with the rapid accumulation of irreversible disability 
(i.e., an incomplete recovery from the initial neurologic episode, a short interval between the first 
two episodes, and a high rate of relapses during the first years of the illness (Weinshenker et al., 
1991)). Evidence from the PP form of MS indicates that irreversible disability may occur without 
superimposed relapses. The rate of disability accumulation in these forms of the disease is 
similar to that seen in the PR form (Cottrell et al., 1999). In general, relapses occur in an 
unpredictable way, since their frequency varies between individuals as well as within a given 
individual. Apparently, progression pursues its course independent of individual relapses, 
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whereas relapses can be superimposed over and above the process of progression. In RRMS, a 
short-term confirmed increase in disability depends primarily on relapses and is often reversible. 
To get a better understanding of the difference between MS types, a comparison summary is 
provided below for the cases where major differences are recognized.  
 
5.1.2.1 Secondary-progressive MS and relapsing-remitting MS 
SPMS and RRMS share the same distribution of initial symptoms during the RR phase, 
the degree of remission from the first relapse, and the period between the onset and the second 
neurologic episode (Minderhoud et al., 1988). Most RRMS patients eventually become SPMS.  
 
5.1.2.2 Primary-progressive and progressive-relapsing MS 
No major differences could be observed clinically and demographically, when comparing 
these two forms of MS. This holds true for the rates of irreversible progression of PRMS and 
PPMS. However, PRMS tends to start at earlier age compared to PPMS (median age 37 
compared to 41). (Confavreux et al., 1980). 
 
5.1.2.3 Secondary-progressive MS and PPMS 
These two types of MS do actually differ. For instance, the clinical manifestation, the 
onset age and the time it takes to reach a debilitating state are different between SPMS and 
PPMS (Confavreux and Vukusic, 2006). The latter is more dominant in male subjects 
(McDonnell and Hawkins, 1998). The former, on the other hand, tends to have a more rapid 
disability accumulation rate and occurs at a younger age than the latter.  
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5.2 - MS patients 
5.2.1 Age at onset of Multiple Sclerosis 
From a percentile perspective, the distribution of patient onset by age is as follows: 10% 
for 20 years old or younger; 70% between the ages 20 to 40 years old and 20% for subjects 40 
years and older. Any onset after the age of 55 years is more likely to be questioned whether this 
is indeed an MS attack (Confavreux and Vukusic, 2006, 2008). Females often seem to have a 
slightly younger mean age at onset than males. Furthermore, the female/male ratio is usually 
found to decrease as age at onset increases. 
 
5.2.2 Genetic and environmental factors 
Multiple sclerosis has always been thought to be more common in women and whites 
(Frohman et al., 2008). Although the former still hold true, newer studies reported that MS is 
more common in African American females and more threateningly progressive in African 
Americans in general (Langer-Gould et al., 2013). They believe that this might be related to their 
vitamin D deficiency due to the darker skin tones. On the other hand, Hispanic and Asian 
individuals are at lower risk compared to other races. The disease is also common within families 
with a known history of MS which may be due to the set of immune response genes (built upon 
the exposure to triggering factors such as viral infections). 
 
5.2.3 Initial symptoms and signs 
Initial symptoms in MS (Confavreux and Vukusic, 2006) may be isolated optic neuritis 
(15%), isolated brainstem dysfunction (10%), isolated dysfunction of long tracts (50%), and 
various combinations of these symptoms (25%). There was no influence of gender on initial 
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symptoms. However, an obvious influence of age at onset has consistently been found 
(Confavreux and Vukusic, 2008). 
 
5.2.4 Initial course 
It is estimated that the initial course of MS is RR in 85% of the cases and progressive in 
15% (Confavreux et al., 1980). RRMS is more common in female subjects while progressive MS 
is more prominent in men. Subjects diagnosed with long tract dysfunction (presence of motor, 
sensory, or sphincteric disturbances) tend to follow the progressive course of the disease. On the 
other hand, patients diagnosed with optic nerve and brainstem symptoms are mostly diagnosed 
with RRMS (Confavreux et al., 1980).  
 
5.2.5 Remission  
The duration of the ongoing neurologic episode is the key element in the MS prognosis 
(the probability of improvement) (Kurtzke et al., 1973). Usually, there is a high chance of a 
second neurologic episode immediately following the initial episode (but not in the cases of optic 
neuritis), and this probability progressively decreases afterwards. Clinical factors (such as gender 
and age) may also influence the rate of occurrence of the second neurologic episode in MS, but 
according to many studies, no clinical factor has had a strong correlation with initial symptoms, 
degree of recovery from the initial episode, and a RR or SP overall course of the disease 
(Confavreux et al., 1980). The probability of developing a second episode (although lower) was 
similar for optic neuritis, spinal cord syndromes, and brainstem-cerebellar symptoms (Tintore et 
al., 2005). This probability increases with the number of T2 lesions and volume on the MR 
image (Kappos et al., 2006). On the other hand, juxtacortical, infratentorial and periventricular 
51 
 
 
lesions do not predict whether a second neurologic episode will take place or not (Barkhof et al., 
1997).  
 
5.2.6 Relapse frequency 
A huge variation in relapse frequency has been seen in MS patients. In RRMS, the yearly 
rate is estimated on average to be equal to 0.5 relapses per year. As the disease duration 
increases, the relapse rate tends to decline overtime. However, this statement has been 
contradicted by a 3-year longitudinal study which showed that the relapse rate was not 
influenced by overall disease duration (Goodkin et al., 1989). 
 
5.2.7 Onset of progression 
The time to enter the secondary progression phase is estimated to be 19 years on average 
following an RR onset in MS. However, the time to onset of progression has been shown to be 
strongly age dependent. For instance, patients diagnosed with RRMS at an older age tend to 
enter the progressive phase more rapidly (Confavreux et al., 1980; Trojano et al., 1995). Each 
year, 2% to 3% of the RRMS patients enter secondary progression. This rate is highly associated 
with gender, initial clinical symptoms, rate of recovery after the initial attack, the time period 
between the initial and secondary attack, as well as the relapse frequency (Confavreux et al., 
1980; Trojano et al., 1995). 
 
5.2.8 MS in children 
Although it is rare, onset of MS in children has been reported (Hynson et al., 2001). The 
ratio of female to male is higher in children (3:1) compared to adult subjects (2:1). A difference 
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in clinical outcomes is seen between children and adults in the early stages of the disease 
although a similar pace is seen when the progressive phase is reached. Childhood onset MS 
patients have been reported to reach the progressive phase at a younger age compared to adult 
onset MS patients (Renoux et al., 2007). 
 
5.2.9 Survival in MS 
After being diagnosed with MS, the median survival for MS patients is 28 years for male 
and 33 years for females (Bronnum-Hansen et al., 2004). Compared to healthy controls, MS 
patients tend to live 10 years shorter compared to the age matched healthy controls. In addition, 
median survival from onset is higher in RRMS compared to PPMS (Grytten Torkildsen et al., 
2008).  
 
5.2.10 Living with MS 
The person with MS can go through normal life events as all other members in society. 
This includes natural, accidental and interventional events (such as pregnancy, stress, trauma, 
infection anesthesia, surgery, and vaccinations). However, these patients are more susceptible to 
infection, which re-initiates the MS cascade and results in recurring relapses (Confavreux and 
Vukusic, 2006). 
 
Multiple Sclerosis: Immunological, Cellular, Molecular and Vascular Involvement 
5.3 Immunological approach 
MS has been diagnosed as a multiphasic disorder, producing clinical attacks at different 
times in a patient’s life, and affecting distinctly different CNS injury targets. Therefore, the 
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diagnostic criteria have been expanded to increase the sensitivity and specificity of clinical 
diagnosis (Polman et al., 2005). In the past, MS was only being declared at a time when a patient 
experienced multiple attacks. Nowadays, patients are classified as having MS when they present 
a single event that is not explained by an alternative etiology, or when there is evidence of 
disease seen anatomically using conventional MR imaging criteria. For instance, clinically 
isolated demyelinating syndrome is most typically associated with clear brain or spinal cord 
lesions (Frohman et al., 2003). However, there is little debate today that MS is radiographically 
more active than what is observed clinically over time. The advances in nonconventional MR 
imaging techniques shows a more global MS pathology and it is believed that MS may not be 
truly characterized by ‘‘multiple’’ areas of sclerosis, but rather a ‘‘diffuse’’ representation of 
sclerosis. One of the known landmarks of this disease is the mononuclear cell infiltrates that 
seem to assemble around post-capillary venules within the CNS. This is facilitated by the 
upregulation in the expression of adhesion molecules on cerebrovascular endothelium, serving as 
a scaffolding for the migration of these cells in the brain and spinal cord (Frohman et al., 2006). 
Once in the CNS, these cells contribute in a complex injury cascade that seems to result in 
inflammation and theretofore, leading to neurodegeneration. Hence, acute relapses are thought to 
be related to the development of inflammation within the CNS tract systems (Noseworthy et al., 
2000a). 
 
5.3.1 Inflammatory mechanisms underlying tissue injury in multiple sclerosis 
In MS, it is believed that there is a major change in many regulatory mechanisms which 
disable the proper function of the immune system in identifying and neutralizing foreign bodies. 
In addition, the inability of the immune system to recognize self-epitopes leads to a series of 
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inflammatory reactions, and hence tissue injury. As such, failure of these mechanisms has been 
considered as a central hypothesis within the path of autoimmune disorders.  
In MS patients, T cells (Treg) are actively primed against myelin antigens (Lovett-Racke 
et al., 1998). Their presence seems to affect and correlate with the clinical activity and outcome. 
These pathogenic lymphocytes become resistant to apoptosis, and fail to protect against auto-
aggressive responses. Under these circumstances, one would think that the depletion of T cells 
would be a possible treatment plan to treat MS patients. However, this does not hold true given 
the importance of these cells in maintaining immune homeostasis (Noseworthy et al., 2000a).  
In this section, we will discuss various histopathologic substrates which were unveiled 
from human MS brain investigations. The fork head box P3 transcription (Foxp3) and protein 
levels, which is required for the development and maintenance of the T cells compartment, were 
reported decreased in patients with MS (Fontenot and Rudensky, 2004; Frohman et al., 2006). 
Another study was conducted investigating the population of regulatory T cells (Brusko et al., 
2005). This study showed that the parenchymal CNS infiltrate consisted of B and T cells along 
with macrophages, with the CD8 T cells being enriched and expanded in MS (Babbe et al., 
2000). This study agreed with what is classically reported in RRMS (Crawford et al., 2004). In 
contrast, the improper function of CD8 regulatory T-cells perturbs the effectiveness of the 
immune system, inducing a pro-inflammatory state in MS. This was confirmed when restoration 
of CD8 regulatory T cells worked as an anti-inflammatory mechanism (controlling the excessive 
T cell response) and decreased clinical symptoms (Karandikar et al., 2002). 
Another component of the immune system which seems to be involved in the 
pathogenesis of MS is the humoral immune response. Evidence of antibody synthesis was 
identified in the cerebrospinal fluid (CSF) of MS patients which seemed to be compartment-
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driven. The presence of  these oligoclonal bands in the clinically isolated demyelinating 
syndrome phase strongly predicts the conversion to clinically definite MS (Villar et al., 2008). 
Humoral immune responses involve the production of antibodies resulting from a series of 
complex molecular changes within B cells. Under altered regulatory control mechanisms, the 
immune system might generate B cell-derived antibodies targeted against infectious epitopes, 
which can be structurally homologous to self-tissue epitopes, thereby establishing the possibility 
of cross-reactivity and the development of auto-aggressive immune responses (Levin et al., 
2002) and lead to humorally mediated tissue injury in MS. This process has been documented in 
B cells derived from the cerebrospinal fluid of MS patients (Owens et al., 2003) and has been 
emphasized by a recent study that showed that a selective monoclonal antibody against a B-cell 
developmental protein (CD20) led to a reduction in both clinical and imaging measures of 
disease activity (Hauser et al., 2008). 
 
5.3.2 Epitope spreading 
The alteration of the antigenic specificity of immune responses over the course of the 
disease seems to be relevant to the pathophysiology of MS. These changes take place in the 
cellular and the humoral levels of the immune response to ensure the recognition and 
neutralization of infectious agents. However, under pathogenic conditions, these reactions might 
be targeted against self-antigens, enhancing the reliability of such responses and maintaining the 
disease activity in the MS patients (Frohman et al., 2008). 
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5.3.3 Lymphocyte nomenclature and phenotype 
The immune system provides surveillance diffusely and compartmentally to the entire 
body. TH1 and TH2 phenotypes play a major role in characterizing the behavior of T cells. TH1 
cells release proinflammatory cytokines (interferon-γ, tumor necrosis factor-β, interleukin (IL) – 
12). IL-12 (increase expression) and tumor necrosis factor-β are thought to be associated with 
MS-related disease activity (Balashov et al., 1997). MS patients show augmented expression of 
IL-12 when compared with cells derived from control subjects (Comabella et al., 1998). On the 
other hand, TH2 phenotype (elaborating IL-4, IL-5, IL-6, and IL-1344) is considered as anti-
inflammatory cytokines. TH17 cells that produce IL-17, under the influence of IL-23 or IL-6 and 
transforming growth factor-β, are gaining a great deal of prominence as pathogenic cells in MS 
and other diseases. ‘‘TH3’’ cells also seem to be involved in down-regulation of inflammation. 
Interferons’ anti-inflammatory immune effects have been assessment in many studies (Duda et 
al., 2000; Steimle et al., 1994). In an MS trial, they used interferon-γ to treat a RRMS and was 
shown to initiate new attacks through cellular and humoral immune responses (Panitch et al., 
1987). On the other hand, treatment with a different interferon-β seems showed reduced disease 
activity and clinical symptoms (Duda et al., 2000). Nowadays, modulation of other type of T 
cells are being studied (TH17, IL-17, OL22) which seem to play an important role in the 
pathogenesis of MS (Polman et al., 2005). 
 
5.4 Cellular approach 
Cellular trafficking across different tissues of the body is achieved through molecular 
interventions, which stabilize the cells and make them ready for migration to specific organs. In 
MS, and due to the breakdown of the BBB, an expanded number of cells enter the brain and 
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spinal cord. Part of those cells migrates through the expression of adhesion molecules on the 
endothelial surface of postcapillary venules. The adhesion molecules on the endothelium, 
selectins, facilitate the slowing and rolling of the mononuclear cells (lymphocytes and 
macrophages) on the vessel surface. These cell surface integrin receptors then interact with 
vascular cell adhesion molecule making the mononuclear cells more stabilized (Noseworthy et 
al., 2000a). Once attached to the endothelium, metalloproteinases digest fibronectin and 
basement membrane collagen and creates a channel of passage for the migration of into the brain 
and spinal cord. Once they reach the CNS, these cells mediate damage through a variety of injury 
cascades involving cytokines, chemokines, free radicals, superoxides, antibody- and 
complement-dependent reactions, and changes in ion channels and excitatory amino acid 
mechanisms (Frohman et al., 2006).  
In the pathology of MS, the damage happens in both white matter and gray matter. 
Therefore, inflammation, degeneration as well as the adaptation to injury response are seen in 
both areas. The damage occurs as a result excitotoxicity leading to irreversible damage to the 
axons; hence neurodegeneration. From a cellular trafficking point of view, when demyelination 
occurs, axons recruit new sodium channels to recover proper function (Stys et al., 1992). The 
system, therefore, senses an exaggerated amounts of sodium, thereby driving the molecular 
mechanisms to reduce sodium. All these observations lead to more axonal injury and 
contributing to the progress of the disease (Frohman et al., 2008). 
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5.5 Molecular approach 
5.5.1 Iron 
As we learned from chapter 2, iron is the most abundant metal in the human brain, and 
plays an important role in many metabolic and functional processes (Stankiewicz et al., 2007). 
For instance, iron was shown to be a necessity for the synthesis of oligodendrocytes and a key 
factor in oxygen transport. Ferritin and hemosiderin are considered the two forms of iron storage 
elements in the cells (Quintana, 2007). Due to the importance of iron in the human body, any 
iron misregulation and abnormal iron deposition can result in neuronal death (Moos et al., 2007) 
leading to neurodegenerative diseases such as MS (Abo-Krysha and Rashed, 2008). It has been 
shown that there is a strong correlation between high iron concentrations (abnormal iron 
presence) in the brain and neurodegeneration (Ke, 2003). In MS, iron seen in lesions come from 
myelin or oligodendrocyte residues following demyelination, iron in the macrophages, or a 
resultant of local microhemorrhages following microvascular wall damage. All these sources 
have been strongly correlated with MS pathogenesis as mentioned earlier. On the cellular level, 
new proteins (the stress protein heme oxygenase-1, for example) have been identified as key 
players in iron metabolism. Although their specific role in the pathogenesis of neurodegenerative 
diseases is not yet well-established (Ke, 2003), suppressing heme oxygenase-1 protein has been 
shown to decrease the motor deficits seen in experimental autoimmune encephalomyelitis (EAE) 
models. Free iron is known to cause the formation of highly reactive hydroxyl radicals that can 
trigger cell membrane dysfunction and chronic microglial activation (Haacke et al., 2009a). It is 
believed that, iron in neurodegenerative diseases accumulates through a cyclic inflammatory 
process during which inflammation attracts iron-rich macrophages, leading to increases in the 
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local iron content. This iron accumulation leads to further inflammation and iron deposition, 
causing the system to be self-sustainable (Hammond et al., 2008). 
To emphasize iron involvement in MS, several studies suggest abnormal iron deposition 
in different areas of the brain, such as white matter and gray matter areas (Bakshi et al., 2000; 
Haacke et al., 2009a; Hammond et al., 2008; LeVine, 1997; Neema et al., 2007). This evidence 
of iron deposition has been supported by histological studies as well as by animal models such as 
the EAE. Iron deposition has been typically seen in the neurons and oligodendrocytes (Celius et 
al., 2000) in the thalamus and the putamen (Drayer et al., 1987) as well as in macrophages and 
microglia (LeVine, 1997). To summarize, there have been indications (Brass et al., 2006; Tjoa et 
al., 2005) of correlations between iron deposition, gray matter damage and clinical 
manifestations of MS, providing evidence of the role of iron in the pathogenesis of MS. This has 
been shown in many recent studies where they found that abnormal iron in the gray matter 
structures such as the pulvinar thalamus, the thalamus and the globus pallidus correlates with 
clinical outcomes, lesion load and brain atrophy (Neema et al., 2009; Zivadinov et al., 2010). 
This will be more expanded in chapter 7.  
 
5.5.2 Zinc 
Many studies suggest zinc level alteration in multiple sclerosis (Cunnane et al., 1989; 
Dore-Duffy et al., 1983; Ho et al., 1986). One study reported that zinc levels in erythrocytes are 
significantly elevated  (three-fold higher) in patients with MS versus controls but were 
dramatically decreased during clinically defined attacks (Ho et al., 1986). Zinc level increase 
may be due to altered levels of cholesterol in plasma and erythrocytes in MS patients (Cunnane 
et al., 1989). However, in a later study, zinc levels were reported low in the damaged areas of the 
60 
 
 
CNS in MS (Yasui et al., 1991). These results are in agreement with what we reported in our 
study (Habib et al., 2010), which is the topic of chapter 6.  
 
5.6 Vascular involvement in MS 
Recently, there has been an increased interest in a new theory that MS pathogenesis 
might have both intracranial and extracranial vascular components. In a study by Zamboni et al. 
in 2009 (Zamboni et al., 2009), data has shown that venous obstructions are found in MS patients 
extracranially in one (or more) of the following patterns: severely stenotic jugular or vertebral 
veins in the neck, a stenotic azygous vein, reduced flow in these veins, malfunctioning valves 
and/or the presence of septum. These reduced flow effects lead to what has been defined as 
chronic cerebrospinal venous insufficiency (CCSVI) (Zamboni et al., 2009). More recently, 
several papers have shown a proclivity of MS patients exhibit these vascular abnormalities 
compared to normal controls (Feng et al., 2012b). This association of extracranial venous 
abnormalities with MS is thought to lead to increased stress on the venous system in the brain 
and to either the development of sclerotic plaques in MS. It has also been considered to be a 
source of exacerbation of the immunological cascade. However, the direct relationship between 
venous obstruction, hypertension and inflammation (and hence tissue damage and lesion 
development), is not yet understood. Intracranially, it has been shown that MS patients 
demonstrated significant hemodynamic alterations in veins located around the lesions (Zamboni 
et al., 2007). This study suggests an anatomic relationship between veins and MS inflammatory 
and degenerated areas. They noted that a venous reflux was found in these areas, causing 
inflammatory reaction and specifically expression of surface adhesion molecules. They 
recommended that further investigations should be undertaken, since their study did not compare 
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patients with and without inflammatory neurological disorders, making their conclusions non-
specific (Zamboni et al., 2007). 
 
5.7 Neuronal Involvement in MS 
 Multiple sclerosis is characterized by the presence of focal demyelinated plaques in the 
white matter and gray matter of the brain and the spinal cord (Lassmann, 2008). Demyelinated 
lesions are seen around small veins and venules (as mentioned above) and are believed to exist as 
a result of an inflammatory process. Demyelination is usually followed by a reactive astrocytic 
scar formation resulting in axonal injury and loss. On the other hand, remyelination and repair 
are also seen in MS lesions as newly formed thin myelin sheaths, frequently seen in new lesions. 
This is a landmark which allows physicians to distinguish between MS and other diseases of 
CNS. This process seems not to affect white matter only; but also global changes in the gray 
matter and the normal-appearing white matter (NAWM) have been reported (Filippi et al., 1998). 
The location of MS lesions in the brain and the spine is heterogeneous. However, there is more 
tendency for lesions to develop the area of high vascular density (Zamboni et al., 2007) including 
the periventricular and the subcortical white matter of the forebrain, the optic nerves and chiasm, 
the cerebellar peduncles and the lateral columns of the spinal cord.  
 Active MS lesions contain many inflammatory infiltrates (T and B lymphocytes), some 
plasma cells, and activated macrophages or microglial cells. The debris of the myelin sheaths or 
of destroyed axons are found within the lysosomes of macrophages. Therefore, the stage of 
demyelination can be estimated from the molecular composition of these degradation products 
(Bruck et al., 1995). However, this is not the case in chronic inactive lesions. MR imaging is 
very sensitive in detecting focal white matter lesions but cannot differentiate between partially 
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demyelinated and remyelinated lesions given that they can exhibit the same cell density. 
However, contrast does exist with respect to inactive lesions which show small cell density due 
to the loss of oligodendrocytes (Lassmann, 2008) and NAWM (oligodendrocytes in the 
remyelinated lesions may even exceed that seen in the surrounding NAWM).  
 
5.7.1 Axonal injury and widening of the extracellular space 
An important feature of MS pathology is the axonal destruction within the plaques. These 
axonal injuries occur during the active stage of the lesion (Ferguson et al., 1997; Kornek et al., 
2000; Trapp et al., 1998). In active lesions, axonal density is reduced by 30%, which is due to 
true axonal destruction, as well as inflammation and edema. Axonal loss is expressed much more 
within permanently demyelinated lesions. During the active stage of the lesions, substantial 
axonal injuries occur, while there is a further accumulation of axonal loss in demyelinated 
plaques at late stages (Kornek et al., 2000). However, in both stages, axonal injury is associated 
with inflammation and microglia activation (Ferguson et al., 1997; Kornek et al., 2000). Further, 
there is an association between demyelination and axonal loss with a widening of the 
extracellular space. This widening of the extracellular space is reported to be the result of axonal 
and myelin loss as well as to edema 
 
5.7.2 Focal white matter changes. 
At the early stages of the disease, subtle changes preceding inflammation in MS plaques 
are seen in white matter, which later turn into gadolinium enhanced lesions (Filippi et al., 1998). 
These changes are thought to be driven by microglial activation. The detection of initial tissue 
damage is possible given that multiple active lesions develop very rapidly. Afterwards, these 
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abnormalities exhibits mild inflammation (through lymphocytic inflammatory infiltrates), edema, 
and microglia activation (as well) in patients with progressive MS (Lassmann, 2008).  
 
5.7.3 Diffuse changes in normal appearing white matter 
Diffuse changes in NAWM are commonly seen on MR scans of patients with progressive 
MS and characterized by diffuse signal abnormalities, reduction of N-acetyl aspartate, or other 
quantitative MR indices. These landmarks are seen as secondary effects following axonal 
destruction in focal white matter lesions (De Stefano et al., 1999; Rocca et al., 2003). These 
alterations consist of some perivascular inflammatory infiltrates, small perivenous demyelinating 
lesions, and diffuse astroglia and microglia activation (Allen et al., 2001) depending on the stage 
of MS. For instance, in early stages, these changes represent significant diffusion of myelin 
density accompanied by mild BBB damage and persistent inflammation in the brain; in patients 
with primary and secondary progressive MS however, chronic perivascular and parenchymal 
infiltration of the tissue with T-lymphocytes and profound microglia activation are prominent. 
Therefore, white matter becomes affected globally and an inflammatory reaction within the brain 
compartment drives this diffuse white matter damage. 
 
5.7.4 White Matter Lesions Classification 
 MS is classified as a heterogeneous neurological disease based on its clinical course, 
pathological mechanisms involved as well as its therapy outcomes. This heterogeneity was also 
reported in radiological assessments, and validated in ex vivo and in vivo studies that investigated 
different types of MS lesions.  
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The first study examined the immunological and the neurobiological markers of 83 
biopsies and autopsies from actively demyelinating lesions (Lucchinetti et al., 2000). This study 
was able to classify these lesions into 4 categories. Category 1 (pattern I) revealed high activity 
of T-lymphocytes and macrophages. Category 2 (pattern II) showed the same characteristics of 
pattern I, in addition to the presence of IgG and complement C9neo at the site of myelin 
destruction. These two patterns were mainly centered at small veins and have very well defined 
edges (figure 5.1 A and B). On the other hand, the main difference between these two patterns 
was the mechanism of myelin injury.  Category 3 (pattern III), is similar to pattern I in terms of 
activities (IgG is absent, but was mainly composed of T lymphocytes with macrophages and 
activated microglia. However, these lesions were not centered by veins; instead myelin rims 
were seen around inflamed veins within the demyelinated plaque (figure 5.1 C and D), with 
some cases revealing Balo-like alternative myelinated and demyelinated tissue. This category is 
also accompanies with oligodendrocytes dystrophy. Category 4 (pattern VI) was exclusively 
found in PPMS patients and showed extensive loss of oligodendrocytes and absence of 
remyelinated shadow plaques suggesting that the function of oligodendrocytes is impaired 
(figure 5.1 E-H).  
Another study examined the magnetic characteristics of the MS lesions using magnetic 
resonance imaging (Haacke et al., 2009a). This study compared the visualization of MS lesions 
using different conventional MRI techniques and SWI. While conventional MR techniques 
evaluate water content in the lesions compared to their surrounding tissue (presence of edema for 
instance), SWI assessed their iron content, which we have seen throughout this thesis that is 
abnormally present in MS. 
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Figure 5.1. A and B. Acute multiple sclerosis; pattern II; perivenous confluent pattern 2 lesion 
with macrophage rim at active border. (A, myelin oligodendrocyte glycoprotein (MOG); B, 
CD68). C and D. Acute MS; pattern III; demyelinating lesion with ill-defined borders. The 
perivenous areas around inflamed vessels show lack of macrophage infiltration and 
demyelination (arrows). (C, MOG; D, CD68) E-H. Primary progressive MS; pattern IV lesion. 
Myelin antigens are similarly distributed in the lesions, and DNA fragmentation of 
oligodendrocytes is seen in the periplaque white matter (H). (E, Luxol fast blue (LFB); F, MOG; 
G, myelin-associated glycoprotein (MAG); H, double staining of in situ tailing (DNA 
fragmentation) and cyclic nucleotide phosphodiesterase CNPase [myelin and oligodendrocytes] 
(Lucchinetti et al., 2000). 
 
 
This showed that some lesions were seen on both conventional and non conventional 
methods, while other lesions were seen on only one of these techniques. Lesions seen on SWI 
were further categorized into six different types (Haacke et al., 2009a): a) uniform dark lesions 
on phase images representing uniform iron deposition; b) lesions detected on SWI magnitude 
data only; c) perivenous lesions (similar to pattern I mentioned above) (figure 5.2A); d) 
hypointense rim surrounding MS lesions (which might reveal iron macrophage activity – similar 
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to pattern II seen above) (figure 5.2B); e) lesions with a dark central region (similar to pattern 
III) (figure 5.2C); and f) gray matter lesions (which will be discussed in the next section). 
 
 
 
 
 
 
Figure 5.2: Different types of MS lesions seen on SWI images (Haacke et al., 2009a). 
 
 
5.7.5 Cortical and gray matter pathology 
Until recently, MS was regarded as a disease affecting only the white matter. However, a 
significant number of studies have shown that gray matter, and in particular the cerebral cortex, 
is affected by demyelination (Lassmann, 2008). This occurs in two different ways: cortical 
demyelination and diffuse neuronal loss with cortical atrophy. 
 
5.7.6 Cortical demyelination 
There are 3 different types of cortical demyelinated lesions: corticosubcortical, 
perivascular, and subpial cortical lesions. Corticosubcortical lesions result from the expansion of 
white matter lesions into the cortical tissue (Figure 5.3). Perivascular lesions are identified as 
small intracortical scars. Subpial lesions are mainly found in patients with progressive disease 
and are the most abundant in MS (Bo et al., 2003; Kidd et al., 1999). The locations of subpial 
cortical lesions are mainly in cortical sulci and deeply in the outer surface of the brain. Cortical 
demyelination are sometimes also seen the cerebellum and the hippocampus. The extent of 
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cortical demyelination is high in patients with primary or secondary progressive MS and it 
increases with disease duration. Subpial demyelination appears to be highly MS specific 
(Kutzelnigg et al., 2005). Corticosubcortical lesions are the only Gd-enhanced lesions compared 
to other cortical demyelinated lesions. BBB damage in the white matter parts of the lesions may 
lead to protein extravasation and edema, which may also penetrate into the adjacent cortical 
areas. Neuronal density is reduced in cortical lesions and in the adjacent normal-appearing cortex 
(Wegner et al., 2006). In active cortical lesions, neuronal apoptosis and some dystrophic axons 
are seen (Albert et al., 2007). Remyelination is frequently encountered and more pronounced in 
cortical MS lesions as in white matter lesions (Albert et al., 2007). 
 
 
Figure 5.3: The three types of cortical lesions (Bo et al., 2003). a) corticosubcortial lesions; b) 
perivenous lesions (intracortical scars); c) subpial cortical lesions – CTX: cortex, WM: white 
matter. 
 
5.7.7 Cortical atrophy 
MR imaging studies showed that cortical volume decreases with time in MS patients. 
Moreover, neuronal and glial cell loss was seen in the demyelinated, but not in the normal 
cortex. This neuronal loss in the cortex is thought to be directly related to inflammatory tissue 
damage (Lassmann, 2008). 
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5.7.8 Remyelination 
Myelin repair within the lesions has been noticed in many systematic studies. 
Remyelination is initiated in the early stages of lesion formation in many cases, but this newly 
formed myelin may be unstable and subject to subsequent demyelination, i.e. remyelinated 
lesions can be affected again by new demyelinating attacks (Prineas et al., 1993). Remyelination 
may lead to complete restoration of myelin within the entire plaque. In early stages of lesional 
activity, recruitment of new oligodendrocytes takes place and the formation of new thin myelin 
sheaths becomes more frequent (Prineas et al., 1989). On the other hand, remyelination fails in 
the later progressive stage of the disease. Extensive remyelination is seen in patients who die at 
very old ages and with long-standing disease (Patani et al., 2007). Evidently, only when the 
inflammatory disease process becomes inactive can remyelination become stable and permanent. 
 
5.8 Correlational interpretations 
5.8.1 Blood-brain barrier damage and inflammation 
Using gadolinium (Gd) based MR techniques makes it possible to assess BBB damage in 
MS to a certain extent. BBB disturbances were seen in active lesions, in inactive plaques as well 
as in normal-appearing white matter with different degrees. Leakage of Gd has become a very 
useful tool to determine the activity of the disease process in clinical setting and therapeutic 
approaches. Gd enhancement characterizes the newly forming lesions in the brain and spinal 
cord (Miller et al., 1988). This enhancement of the new forming lesions was seen to be 
associated with inflammation (Bruck et al., 1997). On the other hand, in the progressive stage of 
the disease, Gd-enhancing lesions are rare or absent, given that most of the lesions become 
chronic, and does not correlate with inflammation.  
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The relationship between BBB disturbances and inflammation is complicated 
(Hochmeister et al., 2006). Massive BBB disturbances seen in classic active MS plaques is 
generally associated with intravascular and perivascular inflammatory infiltrates (Hochmeister et 
al., 2006; Kutzelnigg et al., 2005). Mild disturbance of the BBB, which seems to be below the 
detection limit of Gd enhancement, is seen in some of the inflamed or not inflamed vessels at this 
stage. Many vessels, however, show profound leakage of serum proteins and evidence for leaky 
endothelial cells in the absence of inflammatory infiltrates (He et al., 2005). This has been 
validated in MS by using a joint Gd - ultra small superparamagnetic particles of iron oxide 
(USPIO) approach. USPIO helps visualize macrophage activity in vivo and Gd reveals any leak 
in BBB.  In animal studies (Dousset et al., 2006) as well as in a human subjects studies (Tourdias 
et al., 2012), the authors were able to characterize the MS lesions as follows: a) lesions enhanced 
with Gd and USPIO; b) lesions enhanced with Gd only; and c) lesions enhanced with USPIO 
only. The authors concluded that what is seen with USPIO is unique and complementary to what 
is seen with Gd and will better help to reveal myelin injury mechanisms in vivo. 
 
5.8.2 BBB damage and active demyelination 
Classic active lesions are infiltrated by macrophages that contain myelin degradation 
products in different stages of digestion (Bruck et al., 1995). Active plaques have a peripheral 
rim of ongoing myelin destruction that show dense inflammatory infiltrates and a broad rim of 
activated macrophages. Thus, there is no correspondence between the absence of Gd-
enhancement on MR imaging scans and lesions that are inactive in terms of inflammation 
(mentioned previously), ongoing demyelination, or tissue injury. 
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The prognosis of Multiple Sclerosis 
MS is characterized by a steady and stable rate of accumulation of neurologic 
abnormalities that can be observed at an individual level. What differs among patients is the 
individual slope of the neurologic deterioration. Several factors usually affect the prognosis. For 
instance, older age at onset, dysfunction of long tract-related initial symptoms, progressive initial 
course, and male gender are associated with a worse outcome, whereas the combination of 
younger age at onset, optic neuritis as initial symptom, RR initial course, and female gender is 
associated with a better prognosis. The initial course of MS is the most influential factor in the 
prognosis. The second most important factor in prognosis is age at onset. Initial symptoms and 
gender have a very small effect compared to initial course and age at onset. Abnormalities in the 
baseline brain MR image have a predictive value as well. MR imaging findings are predictive for 
the development of MS and T2 lesion volume and its changes at earlier time points are predictive 
of later disability. For example, the rate of increase in the T2 lesion volume has been seen to be 
three times higher in those who converted to SPMS than in those who remained in the RR stage 
at follow-up. The search for other paraclinical factors that could be predictive of the outcome has 
not been promising so far. For instance, the presence of the HLA-DR15 allele does not 
significantly correlate with the course and severity of the disease (Celius et al., 2000; Runmarker 
et al., 1994). Moreover, the issue of the presence of apolipoprotein E alleles is still inconclusive. 
According to several large series of patients with MS, the epsilon 4 allele is associated with a 
rapid accumulation of disability (Chapman et al., 2001) and an accelerated evolution of brain 
MR imaging abnormalities (Fazekas et al., 2000). Currently, only MR imaging can provide 
useful information for clinical evaluation. 
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 To conclude, the following are important findings in the prognosis of MS. First, the 
predictive factors of the disability accumulation in MS are essentially the same as those that are 
predictive of SPMS, which is not really surprising. Second, two phenomena seem to be 
operating: a weak interplay between relapses and prognosis contrasting with a strong interplay 
between age and prognosis.  
In the next 3 chapters, we will focus on two of the previously mentioned aspects: 
assessing the molecular component (specifically iron) using magnetic resonance imaging and X-
ray fluorescence and its correlation with the vascular component (by investigating a probable 
vascular model of MS). 
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Chapter Six 
VISUALIZING IRON DEPOSITION IN MULTIPLE SCLEROSIS  
CADAVER BRAINS 
Introduction 
For decades, multiple sclerosis (MS) has been understood as an inflammatory 
demyelinating and neurodegenerative disease of the central nervous system (CNS) (Noseworthy 
et al., 2000b). The risk factors for and sequence of events triggering MS are poorly understood 
(Bielekova and Martin, 2004).  Until recently, the focus of research into this complex disease has 
been on immunological (Frohman et al., 2008; Prineas et al., 2001), neurological (Allen et al., 
2001; Filippi and Rocca, 2009; Sharma et al., 2006; van Waesberghe et al., 1999), cellular 
(Connor and Menzies, 1995) and molecular (Dore-Duffy et al., 1983; Forge et al., 1998; Grant et 
al., 2003; Ho et al., 1986; Stankiewicz et al., 2007; Walton and Kaufmann, 1984; Zamboni, 
2006) events. A few early studies suggested that vascular anomalies may lead to MS (Adams, 
1988; Fog, 1964; Schelling, 1986) and this hypothesis is now being reexamined by Zamboni and 
others (Adhya et al., 2006; Ge et al., 2005; Ge et al., 2009; Inglese et al., 2007; Law et al., 2004; 
Rashid et al., 2004; Singh and Zamboni, 2009; Zamboni, 2006; Zamboni et al., 2009; Zamboni et 
al., 2007). Zamboni refers to the resulting vascular effects on the brain as “chronic cerebrospinal 
venous insufficiency” or CCSVI (Zamboni et al., 2009) that leads to iron deposition in the vessel 
walls (Zamboni, 2006), in the venous drainage system (Haacke et al., 2010b)  and in and around 
MS lesions (Haacke et al., 2009a). MRI studies using susceptibility weighted imaging (SWI) 
have shown that many patients have iron overload in at least one of the structures of the basal 
ganglia (Haacke et al., 2010b). A new extension to SWI called susceptibility mapping or SWIM 
(for short) will make it possible to better quantify iron content without the phase artifacts present 
in SWI. Both SWI and SWIM could be powerful tools to detect and quantify perivascular iron in 
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vivo (Haacke et al., 2007). Other MR techniques have been used for iron quantification in vivo 
(such as T2 and phase based-sequences) (Bakshi et al., 2002; Haacke et al., 2007; Xu et al., 
2008) and ex vivo (such as synchrotron X-ray fluorescence (Gh Popescu et al., 2009; Popescu et 
al., 2009a; Popescu et al., 2009b) and histological staining (Hallgren and Sourander, 1958). 
Recently, rapid-scanning X-ray fluorescence (Popescu et al., 2009a; Popescu et al., 2009b) (RS-
XRF) has been used to simultaneously and quantitatively map iron, copper and zinc in single 
slices of whole human brain (Popescu et al., 2009b). In this study, SWI and RS-XRF were used 
in parallel on the same brain slices to evaluate SWI as a tool to image iron in MS.  
 
Materials And methods 
Samples: Two formalin fixed MS cadaver brains were obtained from the Human Brain 
and Spinal Fluid Resource Center (HSB), Los Angeles, CA under University of Saskatchewan 
ethics approval (BioReb 06-250). We will refer to these two MS brains as MS1 and MS2. MS1 
(HSB # 3816) is a coronal section from a 47 year old female who was clinically diagnosed with 
multiple sclerosis and the gross and microscopic description provided in the HSB 
neuropathology were consistent with chronic active MS plaque formation. The post mortem 
interval for this brain was 20.7 hours. There was extensive irregular demyelinating peri-
ventricular plaque formation throughout the extent of the body of the right and the left lateral 
ventricles with satellite extension into the respective corona radiata and the left basal ganglia 
(figure 6.1 - upper).  There was prominent macrophage activity and perivascular lymphocytic 
cuffing. MS2 (HSB# 3867) (figure 6.1 – lower) is a coronal section from a 75 year old male, 
diagnosed with MS who died of a heart attack. The postmortem interval for this brain was 12.9 
hours. The gross neuropathology report was consistent with chronic MS plaque formation with 
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mild atherosclerosis involving the basilar cerebral vasculature. Moreover, microscopic study 
showed prominent decrease in oligodendrocyte density but no macrophage activity or 
perivascular lymphocytic cuffing. 
 
Magnetic Resonance Imaging: MR images were collected at the MR Research Facility, 
(Wayne State University, Detroit, MI, USA) on a 3T Siemens Verio system using a gradient 
echo based SWI sequence (α = 15o, TE = 20 ms, TR = 35 ms) and a T2 weighted Fluid 
Attenuated Inversion Recovery (FLAIR) sequence. For SWI, images were acquired with 0.5 mm 
resolution in the phase and readout directions, and 1 mm in the slice direction with a bandwidth 
(BW) of 120 Hz/pixel, a field-of-view (FOV) of 256mm x 192mm and displayed on a 512 x 384 
matrix. The parameters for FLAIR sequence acquisition were as follows: (α = 150o, TE = 74 ms, 
TR = 9000 ms, with 1 mm
3
 resolution, BW = 250 Hz/pixel and FOV of 256x192).  
MR phase images were post-processed using high pass filtering with a central 64 x 64 
matrix (Haacke et al., 2009b) zero-filling to create the SWI filtered phase images. These were 
used as input into the SWIM algorithm to create quantitative susceptibility maps using SPIN 
software (Signal Processing in NMR, Detroit, MI, USA). The background gelatin fill was 
confirmed to have zero phase (2048 phase units).  The SWIM post processing technique is used 
to map out the susceptibility difference between structures.  
Magnetic susceptibility is a quantitative measure of a material’s tendency to interact with 
or distort an applied magnetic field. The volume susceptibility of iron measured in this paper is 
affected by the spin status (for example Fe
3+
), the type of molecule, the number of iron atoms in 
the molecule, the molecular weight, the concentration of molecule in the volume, tissue density 
and others. In pathological cases, many factors are not known yet. Thus, the exact relationship 
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between susceptibility and iron concentration varies in different structures and pathologies, and 
is still under investigation. In this paper, we have included the iron concentration (µg/cm
2
) as 
measured by XRF.  
 
Figure 6.1. Optical images of the two MS brains. Upper: MS1, Lower: MS2. Black arrows point 
to visualized iron deposition. 
 
X-Ray Fluorescence: RS-XRF imaging was performed at wiggler beam line 10-2 at the 
Stanford Synchrotron Radiation Lightsource (SSRL). The incident beam was set at 12 keV and 
was vertically collimated onto a Si (111) monochromator. The incident beam intensity was 
monitored using a nitrogen-filled ion chamber upstream of a tantalum aperture. This aperture 
produced a 100 μm x 100 μm spot on the sample with the approximate escape depth of 310 μm. 
The samples were mounted on a set of motorized stages oriented at 45° to the incident beam to 
minimize scatter, and raster scanned in the beam with a dwell time of 35 ms/point. A single 
element silicon drift detector was placed at 90° to the incident beam. Energy windows were 
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centered ([8.380 - 8,980] Kev for Zn and [6.210 - 6.700] Kev for Fe) to collect fluorescence 
counts from the emission lines of Fe Kα1 and Kα2 emission lines averaged at a mean Kα energy 
of (2E×Kα1 + E×Kα2)/3, all other biologically interesting elements, scatter and total incoming 
counts. Data were normalized against incident energy (I0). 
The data were quantified using XRF standard foils (Micromatters Inc.) using Sam’s 
Microanalysis kit (http://ssrl.slac.stanford.edu/~swebb/smak.html) with the output units of ‘μg 
Fe/cm
2’
 
 
RESULTS 
MS case 1: Iron, as identified by XRF (figure 6.2a) matches well visually with the SWI-
phase image (figure 6.2d).  The maximum levels of iron from the different structures was 
quantified and ranged from a low value of 2.08μg/cm2 (in white matter) to a highest 
concentration of 62.56μg/cm2 next to the vein draining the caudate on the left side of the brain 
(figure 6.2b).  
Iron values near vessels in the globus pallidus and on the left side were about 
62.56µg/cm
2 
(figure 6.2b).  The overall amount of iron in the basal ganglia on the right side 
seemed lower but this may be due to a slight difference in the section plane.  However, the 
thalamus on the right side has more iron than its corresponding structure in the other hemisphere. 
Because myelin is rich in zinc, demyelinated regions show very low zinc.  These regions 
(figure 6.2e (black arrows)) correlate well with plaques visible with fluid attenuated inversion 
recovery (FLAIR) (figure 6.2f (white arrows)).  Iron is slightly elevated at the periphery of 
several demyelinated plaques. 
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MS case 2: XRF measured iron in the white matter and gray matter, specifically in the 
deep gray matter structures (thalamus (figure 6.3a) and basal ganglia (figure 6.3a and b)) of this 
case is similar to those in case 1 (figure 6.2a,b) ranging from 2.21 to 17.52 µg/cm
2
.  
MS case 2 shows abundant iron in the basal ganglia that appears to be normal. Iron in the 
basal ganglia in both hemispheres matches well between the XRF and SWI-phase image (figure 
6.3a, c and d). We did not detect any large perivascular iron deposition similar to that seen in MS 
case 1 but halos of iron and zinc decrease were seen at the periphery of and in some 
demyelinated plaques (figure 6.3c, d, e and f).  
Given the increased interest in CCSVI as a risk factor for MS, we sought to determine if 
SWI might be an effective means to visualize iron deposits in MS brain by using a parallel 
imaging strategy in which the presence of iron was independently confirmed using element-
specific XRF mapping. The advantage that SWI has is that it can be run on patients to monitor 
iron content. It remains to be determined if phase as seen with SWI is in fact directly related to 
iron content and not coming from other elements. SWI has also been shown to reveal MS lesions 
that were not visualized with conventional T2 weighted imaging. This iron content can be either 
from heme or non-heme (such as ferritin or hemosiderin) sources.  
 
DISCUSSION 
 Single echo and multi-echo SWI sequences were acquired in this study. Multi-echo SWI 
data were processed to calculate T2* maps which have been used to correlate with iron content 
in the past. However, the T2* maps in this cadaver brain study did not appear to correlate with 
iron content. This could be because of the confounding effect of local water content which 
causes an increase in T2* counter-balancing the decrease in T2* caused by the presence of iron. 
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Confounding effect of local water content was also seen in some but not all MS lesions detected 
using FLAIR images, where high signals were visualized in corresponding high iron content 
regions on XRF images. 
 
Figure 6.2: Comparison between different acquired MRI sequences showing MS lesions, iron 
and zinc deposition in MS1: a. XRF Fe map; b. Magnification of selected regions in (a), unit 
µg/cm2; c. Fe susceptibility mapping; d. SWI phase; e. XRF Zn map, f. FLAIR 
 
In summary, these preliminary results show a good correlation with iron as seen with 
SWI and SWIM and that seen with RS-XRF. High iron content often correlated with low zinc 
content as might be expected when there is a depletion of oligodendrocytes. Future work in this 
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direction should include the creation of a one-to-one quantitative mapping of RS-XRF data with 
SWIM data. This would make the in vivo use of SWI more available as a quantitative 
methodology to map iron for patients with multiple sclerosis. 
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Chapter Seven 
ASSESSING IRON CONTENT IN THE DEEP GRAY MATTER OF MS PATIENTS 
AND HEALTHY CONTROLS 
Introduction 
Multiple Sclerosis (MS) has been considered as both an autoimmune inflammatory 
demyelinating disease (Lassmann et al., 2007) and a disease where venous involvement is 
recognized as a possible biomarker or representing some specific damage to the tissue 
(Schelling, 1986). Recently, the inter-relationship between venous abnormalities, obstructed flow 
and a possible role for iron in tissue damage has been considered (Singh and Zamboni, 2009; 
Zamboni et al., 2009).  
To a large degree, but not exclusively, the imaging pathogenic landmarks of MS have 
been well documented mostly in white matter (WM) (Filippi et al., 1998; Haacke et al., 2009a). 
To a lesser degree, investigators have noticed abnormalities in cortical regions as well, 
specifically near the gray matter (GM)/WM boundary and in gray matter as well (Haacke et al., 
2009a; Nelson et al., 2007). However, determining whether the starting point is in the GM or 
WM is still unclear (Allen et al., 2001; Neema et al., 2009; Nelson et al., 2007). Currently, there 
is an increased  interest in studying how GM  is affected (Filippi and Rocca, 2009; Haacke et al., 
2009a; Varga et al., 2009) and particularly deep GM involvement in MS where iron deposition 
has been observed (Adams, 1988; Eissa et al., 2009; Haacke et al., 2009a). Brain iron 
accumulation in neurodegenerative diseases, including MS, is not new and has been shown 
histologically in the past (Craelius et al., 1982; Levine and Chakrabarty, 2004).  In MS, its 
source is likely due to myelin or oligodendrocyte debris, concentrated iron in the macrophages, 
or as a product of local microhemorrhages following venule wall damage (Adams, 1988; Haacke 
et al., 2009a). As the wall breaks down, free iron may escape outside the vessel. This process has 
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typically been seen in the basal ganglia, neurons, oligodendrocytes, macrophages and microglia 
(Haacke et al., 2009a). Generally, free iron is known to lead to the formation of highly reactive 
hydroxyl radicals that can trigger cell membrane dysfunction (Gutteridge, 1992) and chronic 
microglial activation (Lassmann et al., 2007). Thus, iron from any of the above mentioned 
sources could lead to inflammation, and a further buildup of iron, causing the system to be self-
sustainable (Hammond et al., 2008). When iron is present, the result is a hypointense signal on 
T2 or T2* weighted images and a change in the phase for susceptibility weighted imaging (SWI) 
(Haacke et al., 2010a; Neema et al., 2009; Zivadinov et al., 2010) which makes it possible to 
quantify iron changes in vivo. Different results have been reported in studying iron involvement 
in MS. The variations seen in these results have been related to many factors including the type 
of MS studied, the sample size recruited and the methodologies used to assess iron deposition. 
From these studies, a number of papers have now shown that there are increases in iron in the 
basal ganglia and the thalamus (Haacke et al., 2010a; Hammond et al., 2008; Zivadinov et al., 
2010). In a recent study (Zivadinov et al., 2010), high iron was found in the pulvinar thalamus, 
the thalamus and globus pallidus and they considered the iron measured by SWI to be a strong 
indicator of disability progression, lesion volume accumulation and atrophy. Another study by 
Burgetova et al (Burgetova et al., 2010) using T2 relaxometry showed that iron does increase  in 
the basal ganglia and the thalamus of MS patients but showed an inverse correlation with lesion 
load. Zhang et al. (Zhang et al., 2010) also reported a correlation between T2 hypointensities 
(representing iron deposition) and the patients' disabilities of the relapsing remitting MS group 
they studied. Ceccarelli et al (Ceccarelli et al., 2010) investigated deep GM T2 hypointensity in 
clinically isolated syndrome (CIS) MS patients and showed that iron related changes and 
neurodegeneration can both occur in the early stages of MS. Recent work investigated the 
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potential role extravasated iron might play by studying CSF ferritin levels, which is considered 
an indirect measure of iron in the brain (Worthington et al., 2010). They found no difference 
between the MS population and the control group. Another study (van Toorn et al., 2010) noted 
that iron deficiency was reported in their MS group studied and iron supplementation was 
prescribed to these people. Evidently, this treatment resulted in a partial recovery of their 
symptoms. Thus, the role of iron in MS and its correlation with the clinical outcomes is still 
unclear and new approaches to investigate brain iron in MS patients are still needed. In this 
multidisciplinary work, we study a group of 52 MS patients using SWI, which is a powerful MR 
methodology known to be sensitive to iron. We also present a new weighting scheme to evaluate 
iron abnormalities and better differentiate between what is considered normal and abnormal iron 
deposition. 
 
Materials and Methods 
Data Acquisition 
Fifty-two (52) clinically definite MS patients were imaged (mean age: 43, standard 
deviation: 11.73, range: 17 to 66 years) under four separate Internal Review Board approved 
protocols. One hundred and twenty-two (122) normal subjects (mean age: 44, standard deviation: 
13.49, range: 20 to 69 years) were included in this study to establish a normal range of iron 
deposition in the structures of interest. The patient population studied covered 2 types of MS 
including RRMS (31) and SPMS patients (21) (RRMS mean expanded disability status scale 
(EDSS): 2.19, EDSS range: 1 to 5.5, mean disease duration: 8 years ; SPMS mean EDSS: 5.92, 
EDSS range: 3 to 7.5, mean disease duration: 19 years). All patients and controls consented to be 
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subjects in this study.  A velocity compensated, 3D gradient echo sequence was used to generate 
SWI images.  
Site 1:  Twelve (12) MS patients were recruited at the Detroit Medical Center, Detroit, 
MI, USA for this study. SWI data were acquired on a 1.5T Sonata scanner (Siemens Medical 
Solutions, Erlangen, Germany) equipped with an 8-channel head coil. Imaging parameters for 
SWI were: repetition time (TR) = 57ms, echo time (TE) = 40ms; flip angle (FA) = 20°, 
bandwidth (BW) = 80 Hz/pixel, Field of View (FOV) = 256x192 mm
2 
, matrix size 512x448), 
with a resolution of 0.5x0.5x2mm
3
.  
Site 2: Thirty-one (31) MS patients and 18 normal subjects were scanned on a 3T GE 
Signa Excite HD 12.0 Twin Speed 8-channel scanner (General Electric, Milwaukee, WI, USA) 
at the University of Buffalo, Buffalo, NY, USA. A multi-channel head and neck coil was used to 
acquire the SWI data. The imaging parameters were: TR=40ms, TE=22ms, FA=12°, and 
FOV=256x192mm
2
 (512x256 matrix with PhaseFOV = 0.75) and image resolution of 
0.5x1x2mm
3
. 
Site 3: Nine (9) MS patients were scanned using a 3T Siemens TIM Trio system 
(Siemens Medical Solutions, Erlangen, Germany) at Jena University Hospital, Jena, Germany. A 
12-channel receive head-matrix coil was used to acquire the SWI data. The imaging parameters 
were: TR=29ms, TE=20ms; FA=15°, BW=120 Hz/pixel, FOV= 256 x 192 mm
2
, matrix 512x256 
with FoV Phase=0.75, corresponding to an image resolution of 0.5x1x2mm
3
, iPAT = 2 (24 
reference lines), 128 partitions. 
Site 4: The SWI data of another 104 normal subjects (previously studied (Haacke et al., 
2010c)) were added to the 18 normal cases studied in site 2 to create a baseline for iron content 
in the deep grey matter nuclei of healthy subjects as a function of age.   
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The ability to use and compare data from different sites, acquired at different field 
strengths, lies behind the concept that the phase values will remain constant if the product of 
field strength to the echo time is kept constant and is otherwise independent of field strength or 
system manufacturer (Haacke et al., 2009b). Thus, no matter what field strength is used, 
evaluating iron content using phase images should report consistent results. To experimentally 
test this concept, we recruited 36 normal controls from site 1, 2 and 3 who were scanned using 
the parameters specific to each site and analyzed their data.  The results were compared to the 
104 normal cases from site 4 and indeed showed that these measured values (from site 1, 2 and 
3) lay within the normal range deduced from site 4 data.  
 
Data Analysis  
A 64x64 (or equivalent) low spatial frequency kernel matrix was used to complex-divide 
the original k-space data to create an effective high pass filtered phase image (Haacke et al., 
2009b). The resulting SWI filtered phase images were used as a means to quantify iron content. 
The following seven deep gray matter structures were studied for iron content (methodology 
described in previous studies (Haacke et al., 2010a; Haacke et al., 2010c; Zivadinov et al., 2010)) 
including: the globus pallidus (GP), the head of the caudate nucleus (CN), the putamen (PUT), 
the thalamus (THA), the substantia nigra (SN), the red nucleus (RN) and the pulvinar thalamus 
(PT).  
Our in-house software SPIN (Signal Processing in NMR, MRI Institute for Biomedical 
Research, Detroit, MI, USA) was used for the data analysis. Each structure was separated into 
two regions-of-interest: the normal iron content region (RI) and the high iron content region 
(RII). Since our interest was to quantify high iron content, our main focus was on RII and the 
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total region (RI+RII). To achieve this quantification, we used the same process described in more 
detail in Haacke et al. (Haacke et al., 2010c). To separate these two regions automatically, 
thresholds were based on the data from recent papers (Haacke et al., 2007; Miao, 2008). For the 
structures that were not included in these papers (pulvinar thalamus and thalamus), appropriate 
thresholds were calculated by analyzing twenty normal cases with ages ranging from 20 to 39 
years old. Otherwise, the thresholds were set using the mean value measured minus two times 
the standard deviation (SD) across an elderly population to be on the conservative side as 
outlined in Haacke et al (Haacke et al., 2007) and across the above mentioned 20 normal cases. 
The boundary of each structure was drawn manually by three well trained graduate students and 
the high iron content region was found automatically by using threshold values. The intra-class 
correlation coefficient reliability (ICC) was evaluated by comparing the results of 5 different 
subjects from 3 different observers using Statistical Package for Social Sciences (SPSS) 
software. All three observers evaluated the same structure's  average iron content in RII, the 
normalized area and the total iron in the putamen. The ICC values for these measures were 0.71, 
0.93 and 0.81, respectively. SPIN can output the statistical measures of the total structure and the 
high iron content region for later analysis. Different measures have been evaluated (Haacke et 
al., 2010c; Zivadinov et al., 2010): 1) the fraction of the structure that had high iron content 
(percentage area), 2) the average putative iron per voxel in RII and 3) the total putative iron 
content in the high iron content region. The main criterion to differentiate normal from abnormal 
is that the measured iron content should lay outside the 95% prediction interval lines of the 
normal population. Moreover, iron deposition measures were weighted according to their spread 
around the mean values. This abnormality weighting AW (m) was achieved by substracting the 
measured mean value (MV) from the estimated values of normal iron deposition of age matched 
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controls MVn  (calculated from the linear regression) , then subtracting m times the estimated 
standard deviation (SDn)  (m=2 while considering a 95% confidence interval) and dividing the 
results by SDn (equation 7.1). 
 
 AW (m) = ((MV-MVn) – mSDn)/ SDn     (7.1) 
 
In this paper, the results will be shown for both m=2 and m = 3. 
 
Results 
The main purpose of this study was to quantify iron content in the basal ganglia and 
thalamus of MS patients using phase information acquired from SWI data, and create a new 
weighting scheme that allows us to better differentiate between normal and abnormal iron 
deposition in MS patients compared to control subjects. Iron overload was well visualized in MS 
patients in a number of regions related to the basal ganglia and thalamus. Figure 7.1 displays the 
iron content visualized in an age matched control (age 39) and an MS patient (age 40) in the 
basal ganglia and midbrain using SWI. Note that both have iron content in the red nucleus and 
substantia nigra, however, iron overload was only seen in the MS case. High iron deposition  can 
be seen in the CN, GP, PUT and PT of this MS patient. In the normal subject, iron deposition in 
these brain structures is much less and is evenly distributed.  
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Figure 7.1. SWI filtered phase images displaying the basal ganglia and the midbrain of an age-
matched normal control (A, B, C) and MS patient (D, E, F) showing abnormal iron deposition in 
the globus pallidus, putamen and the caudate nucleus (D); the substantia nigra and the red 
nucleus of the midbrain (E); and the pulvinar thalamus (F). 
 
Abnormal iron changes were seen upon visual examination in Figure 7.1, with the 
quantified results appearing in Figure 7.2. Generally, the degree of abnormal iron accumulation 
varied depending upon whether one measures total iron in RII, average iron in RII or the 
normalized percentage area of RII. In Figure 7.2, we display these three measurements for the 
CN and PT as an example to show the abnormal iron content of MS patients relative to normal 
subjects. 
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Figure 7.2. Average phase, normalized area and total phase of RII in CN and PT. Small dots 
represent normal subjects. The solid line is the regression line and the outer dashed lines 
represent the 95% prediction interval of the regression. Hollow squares and triangles represent 
relapsing remitting MS patients and the solid squares and triangles represent secondary 
progressive MS patients. The squares and triangles represent the left and right hemisphere. Many 
of the MS patients have brain iron content beyond the 95% prediction intervals. 
 
 
89 
 
 
 
Figure 7.3: Plots showing individual weighting of different parameters (average phase: upper 
row, normalized area: middle row and the total phase: lower row) of the pulvinar thalamus (A, B, 
C) and the red nucleus (D, E, F). The asterisks represent the RRMS patients, the triangles 
represent the SPMS and the diamonds represent the healthy subjects. MS patients and normal 
subjects with weighting higher than 1 are shown in the plots (these results correspond to m=3 - 
for quantitative evaluation, please refer to table 7.1).  
 
Figure 7.3 displays the individual weighting results calculated using Eq. (1) for the PT, 
and RN. A clear separation between normal subjects and MS was visualized with MS patients 
having iron content higher than 3 times the SD of normal subjects. Figure 7.4 displays the 
subtotal weighting of the 4 structures for each measured parameter including average phase, 
normalized area and total phase. The last graph, Figure 7.4d, shows the total weighting of all the 
parameters of the CN, PT, RN and SN combined.  The figure also demonstrates that there were 
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no normal controls younger than roughly 40 years with abnormal iron content, as reflected by a 
weight factor larger than 1.0.  
 
Figure 7.4: Four plots showing the subtotal (A, B and C) weighting factors and the total 
weighting factor (D) of the four structures with the weighting factor greater than 1 (these results 
correspond to m=3): CN, PT, RN and SN. The asterisks represent the RRMS patients, the 
triangles represent the SPMS patients and the diamonds represent the healthy subjects. For 
quantitative results of these graphs, please refer to table 7.2.  
 
The percentages of patients with abnormal iron content in both control subjects and MS 
patients are shown in Tables 7.1 and 7.2. Note that in these tables, the evaluations and 
calculations were done for both hemispheres thereby resulting in a total which is 2 times the 
number of subjects
*
. In Table 7.1, individual weights (one parameter for one structure), subtotal 
weights (one parameter for all the structures) and the total weights (all parameters for all the 
structures) are displayed for m=2 and m=3 (higher than 2 and 3 times the SD, respectively).  
Comparing normal subjects to MS patients (p<0.05), the total weights showed that 76% of all 
MS patients have abnormally high iron content (higher than 2 SD) in at least one of the 
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structures whereas only 27% of controls have abnormally high iron content. Similar results were 
seen for subtotal and individual weights (except in the putamen). Results  for subjects with iron 
deposition higher than 3 SD still show still  high values for MS patients.   
 
Table 7.1: Abnormal iron deposition weighting (percentage) for normal controls (N) and MS 
patients (P). 
N: Percentage of normal subjects lying above 2 standard deviations from the normal mean 
(p<0.05). P: Percentage of patients lying above 2 standard deviations from the normal mean. The 
dash (–): data not available. 
 
In table 7.2, we display the total and subtotal weights calculated from CN, PT, RN and 
SN iron content that again lies above 2 and 3 times higher than SD (m=2 and 3 in Eq.(1))MS 
patients were divided into RR and SP  and into two age ranges (≤40 and >40). We found that 
27% of the normal population, 74% of RRMS patients and 79% of SPMS patients had iron 
content above 2 SD from the mean while 13% of control subjects have higher than 3 SD iron 
content compared to 67% of SPMS patients and 65% RRMS patients.  The younger RRMS 
population tends to have a higher percentage of abnormal iron deposition compared to normal 
controls. for m=2 and m=3 except for subtotal weight – average phase. 
Total Weights N P 
80.1 29.7 
Subtotal Weights N P N P N P 
RII – Average 
Phase 
RII – Normalized 
Area 
RII – 
Total Phase 
17.2 52.8 17.6 63.2 16.9 52.8 
Individual 
Weights 
CN 4.7 21.6 4.41 19.8 – – 
PT 1.8 29.2 4 34.9 – – 
RN 4.4 35.8 – – 5.8 33.01 
SN 3.3 23.58 4.4 35.8 – – 
GP 4.4 8.4 3.67 10.3 – – 
THA 4.04 21.7 3.67 4.7 – – 
PUT 4.77 3.77 4.41 5.6 – – 
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Table 7.2: Total and subtotal iron content weightings of all the four structures (CN, PT, RN and 
SN) for normal controls and MS patients with iron content higher than 3 standard deviations. 
RR: Relapsing Remitting MS; SP: Secondary progressive MS; TMS: Total number of MS 
patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
*
Both the left and right hemispheres measurements were included in this calculation: therefore, 
since the total number of normal controls is 122, including the left and right measurements 
together will lead to 244 as the total count. This doubling is also applies to the MS population 
studied; there is 62 values quoted for RR and 42 values for SP, yielding a total of 104. 
 
 
 
 
Total Weights 
 RR SP Normal 
 MS/TMS MS/TMS High/Total 
20-40 24/36 (67%) 4/8 (50%) 1/112 (1%) 
41-70 16/26 (62%) 24/34 (71%) 30/132 (23%) 
20-70 40/62 (65%) 28/42 (67%) 31/244
*
 (13%) 
Subtotal Weights – Normalized Area 
 RR SP Normal 
 MS/TMS MS/TMS High/Total 
20-40 19/36 (53%) 4/8 (50%) 0/112 (0%) 
41-70 12/26 (46%) 20/34 (59%) 15/132 (11%) 
20-70 31/62 (50%) 24/42 (57%) 15/244 (6%) 
Subtotal Weights – Average Phase 
 RR SP Normal 
 MS/TMS MS/TMS High/Total 
20-40 16/36 (44%) 6/8 (75%) 1/112 (1%) 
41-70 9/36 (35%) 14/34 (41%) 13/132 (10%) 
20-70 25/62(40%) 20/42 (50%) 14/244 (6%) 
Subtotal Weights – Total Phase 
 RR SP Normal 
 MS/TMS MS/TMS High/Total 
20-40 17/36 (47%) 1/8 (13%) 0/112 (0%) 
41-70 8/26 (31%) 17/34 (50%) 14/132 (11%) 
20-70 25/62 (40%) 18/42 (43%) 14/244 (6%) 
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Discussion  
The interest and association of MS with veins and iron deposition is not new (Haacke, 
2011). We know that the basal ganglia from the dentate nucleus, the midbrain and up to the 
thalamostriate system are all drained by the medial venous drainage system out into the straight 
sinus. It is just these regions that have increased iron content as seen with SWI and with 
conventional MRI (Neema et al., 2009; Singh and Zamboni, 2009). The recent work of Haacke 
et al (Haacke et al., 2010a) suggests that the iron increase seen in MRI occurs at the confluence 
of the small draining veins out of the structures of interest such as the putamen, globus pallidus 
and caudate nucleus. Given the previous evidence that MS is a perivenular disease and that iron 
builds up in the venule wall (Adams, 1988; Zamboni, 2006), it may be that these increases in 
iron represent venous endothelial. However, it is still unknown whether iron deposition is a cause 
or a consequence of the inflammatory demyelinating aspect in MS pathology. On the other hand, 
the work by Neema et al (Neema et al., 2009) showed the presence of deep gray matter T2 
hypointensities and suggested that excessive iron deposition is associated with the progression of 
disease.The plots in Figure 7.3 show that SPMS and RRMS are well separated with a dominance 
of RRMS for younger ages and dominance of SPMS for older ages.  
MR phase information has become more frequently used to evaluate iron content as a 
function of age in the human brain (Ogg et al., 1999; Xu et al., 2008). In a previous paper, we 
introduced the concept of a high iron content region and normal iron content region (Haacke et 
al., 2010a; Haacke et al., 2010c). This made it possible to study not only smaller increases in iron 
content more confidently but also to study both the average iron content per pixel and the 
normalized area of increased iron content with age which showed different and interesting results 
as mentioned earlier (Haacke et al., 2010c; Zivadinov et al., 2010). This approach revealed subtle 
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changes in iron content that cannot be seen with the single region approach because even large 
increases in iron in a small area would be washed out when looking at iron over the whole 
region. The variability shown in our results demonstrates that evaluating abnormal iron content is 
not best achieved by using total iron content measurements. Rather, more information can be 
obtained by evaluating the area of the high iron content region as well as the average iron content 
per pixel. These two measures appear to present better quantitative indicators of iron content 
abnormality. In this study, the CN, PT, RN and SN are shown to be more susceptible to 
abnormal iron deposition than the other structures studied (with RN being the most susceptible 
(30%) followed by the PT (27.9%) - see table 7.1). However, no significant correlation of iron 
content with EDSS was found with any of the measures we did regardless of the structure 
studied. This high iron content seen in the basal ganglia, the thalamus and the midbrain 
structures may be consistent with the hypothesis of venous hypertension (Singh and Zamboni, 
2009).  
 
Conclusion 
Abnormal iron content using the total iron weighting scheme described herein was clearly 
identified in RRMS patients especially those less than 40 years of age with almost no abnormal 
iron seen in the normal population. Evidently, iron in the basal ganglia (CN), thalamus (PT) and 
the midbrain (RN and SN) may be a biomarker for MS. Further work in this direction would be 
to compare iron content with severity of venous disease in chronic cerebrospinal venous 
insufficiency. 
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Chapter Eight 
CEREBRAL VASCULATURE OF SWINE AS A PROBABLE MODEL FOR 
NEURODEGENERATIVE DISEASE 
Introduction 
The use of animal models in research has provided a wealth of information about the 
etiology of many diseases (Batoulis et al., 2011; Chesselet and Richter, 2011; Li et al., 2011; Liu 
et al., 2012; Mao et al., 2012). In multiple sclerosis (MS), which is known to be an inflammatory, 
demyelinating disease, the main etiology remains unknown (Batoulis et al., 2011; Noseworthy et 
al., 2000b). Whether inflammation is the triggering factor or a consequence of the pathological 
cascade is yet to be determined (Haacke et al., 2010a). The heterogeneity of MS pathological 
substrates has led to developing many animal models to address different triggering factors. The 
following models are mainly used: toxic agent induction of MS (Dousset et al., 1995), viral 
models (Schneider, 2009) and experimental autoimmune encephalomyelitis (EAE) models 
(Batoulis et al., 2011). All these models investigate the role of the immune system in MS 
development; however, other aspects including: genetic predisposition, aberrant cranial anatomy, 
vascular risk factors, and traumatic brain injury have shown evidence as potential causative or 
progressive agents to the disease (Damadian and Chu, 2011; Haacke, 2011; Milo and Kahana, 
2010; Ramagopalan et al., 2010), therefore necessitating further investigation.    
Recently, the role of vascular abnormalities in MS has regained a worldwide interest as a 
probable contributing factor to the pathology of MS (Zamboni et al., 2009).  This study of 
Zamboni et al. has shown that extracranial venous anomalies are seen in MS patients and 
strongly correlate with the disease course. This has led researchers to look for a correlation of 
vascular treatment using percutaneous transluminal angioplasty (PTA) with clinical outcomes 
(Zamboni et al., 2011; Zivadinov et al., 2011). Using MRI, it has been shown that MS patients 
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with stenotic internal jugular veins (IJV) also show reduced outflow through these vessels with 
the development of collateral outflow routes and no flow related adaption in the cervical arterial 
system (Feng et al., 2012a; Haacke et al., 2012c). In the 1930s, Tracey Putnam attempted to 
show the critical role of venous drainage by blocking the small veins in the canine brain 
(Putnam, 1935). His results showed that, for the most part, canines developed sclerotic lesions in 
the presence of obstructed blood drainage from the brain. Our goal here is to evaluate the 
vasculature of the Yucatan pig in an effort to prepare for a series of experiments to see if reduced 
venous flow in the pig also leads to the development of sclerotic lesions. If this can be done, it 
would represent a major breakthrough in the understanding of the etiology of MS. Although this 
new theory has been the main drive behind this study, MS is not the only disease with a vascular 
aspect (Haacke et al., 2012a) and, thus, a vascular animal model may well benefit studies on 
vascular related neurological diseases as well. 
The use of pigs (swine) as animal models is not novel approach (Schook et al., 2005). 
The driving force for investigating swine is the fact that their neurovasculature is similar to that 
in humans. Previous swine models have been used to study cardiovascular diseases (Reffelmann 
et al., 2004) as well as neurological disease (Andaluz et al., 2002; Duhaime, 2006; Kornum and 
Knudsen, 2011); however, no one has used these animals to study the cerebrovascular aspect of 
neurological disease. In reviewing the literature, few papers have discussed the anatomy of the 
pig's cerebrovasculature with a focus on the venous side (Ghoshal and Zguigal, 1986; Lavoie et 
al., 2008). Reported results do not agree on how the venous vasculature drains blood from the 
brain. In one study (Ghoshal and Zguigal, 1986),  Ghoshal and Zguigal show that the cerebral 
blood drains along four different pathways while Lavoie et al. (Lavoie et al., 2008) show that the 
blood from the brain drains through only two pathways (see figure 8.1). The disagreement 
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between these two studies comes from the use of different techniques to assess the veins as well 
as the number of pigs used. In this paper, we used magnetic resonance imaging (MRI) to assess 
the pig's cerebrovasculature in vivo in order to understand the venous anatomy of the pig and to 
show the similarities between human and pig vascular anatomy.  
 
Material and Methods 
Animals 
 Three micro Yucatan pigs (swine) have been used in this study and were maintained in 
accordance with the National Research Council’s Guide for the Care and Use of Laboratory 
Animals (2010) at Wayne State University, an AAALAC-accredited institution. All procedures 
were reviewed and approved by the university’s Institutional Animal Care and Use Committee. 
The ages when the pigs were imaged varied between 5 and 7 months. Amongst these three pigs, 
two were female and one was male. The weight of the three pigs was 21, 22 and 23 kg 
respectively.  
 
Preparation for MR scans 
 After the delivery of the animals, all pigs underwent a one week acclimation period. At 
the time of the MR scan, all animals were sedated using 33 mg/kg IM ketamine and 0.5 mg/kg 
IM midazolam and were intubated and manually ventilated. Anesthesia was maintained with 
propofol (12-20 mg/kg/hr IV continuous rate infusion) throughout the duration of transportation 
and the scan.  During scanning, all pigs were positioned at rest on their right side with their head 
facing into the bore.  
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MR protocol 
 Although this study is vascular by nature, the protocol consisted of many MR sequences 
to assess both the structural and functional anatomy of the pig. The protocol included the 
following sequences: an axial 2D time-of-flight (TOF) MR venography (with saturation pulse) 
and arteriovenography (with no saturation pulse) scans for the neck and head vasculature; an 
axial 2D phase-contrast (PC) MR scan for flow quantification; an axial high resolution 3D TOF 
MR arteriovenography of the brain; and sagittal 3D volumetric interpolated breath-hold sequence 
VIBE to assess the vasculature of the brain and neck. 2D PC MRI data were collected to observe 
flow in the extracranial veins of the neck in each of the three pigs at the vertebral levels of C6/C7 
and C3/C4 as well as at the outer base of the cranium.  Additional extracranial flow data was 
collected on the male pig to provide a more comprehensive map of flow including a slice 
positioned perpendicular to flow exiting the cranium, at the inner base of the cranium, and at the 
C1 neck level.  2D PC MRI data were also collected on the male pig through intracranial 
structures of interest: the ophthalmic sinus, dorsal sagittal sinus (DSS), straight sinus (SS), and 
transverse sinus.  In addition: an axial 2D T2 weighted scan; coronal T1 weighted scan; an axial 
fluid attenuated inversion recovery (FLAIR) scan; and susceptibility weighted imaging (SWI) 
scan were collected to assess the structural anatomy of the pig brain. Parameters for sequences 
collected are presented in Table 8.1.  The following scans were collected post contrast agent 
injection: 3D TOF angiography, 3D VIBE and SWI. The contrast agent used was Magnevist 
[Bayer, Wayne, New Jersey] and was injected with a concentration of 0.2 mL/kg [0.1 mmol/kg]). 
The total scan time was one hour and 40 minutes.  
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Data processing 
 Data were processed using Signal Processing in Nuclear MR software (SPIN, Detroit, 
Michigan). This software has been used to create 3D models of the pigs’ vasculature in order to 
visualize and understand the vascular system. SPIN was also used to quantify the flow in all 
vessels through a manually defined cross section at different levels of the neck and head.  
 
Results 
Structural cerebral anatomy of the pig 
 Figure 8.2 displays the axial slices across the whole brain seen on T2 weighted imaging. 
The contrast between white matter, gray matter and the ventricles is well visualized at all levels. 
This contrast was also seen on the T1 weighted images shown in figure 8.3. The T1 weighted 
images, that were originally acquired coronally, are displayed in figure 8.4. This figure shows: 
the cerebral hemisphere; the corpus callosum; the cerebellum; the hypothalamus; the pons and 
the spinal cord. These structures are seen and well defined in the human anatomy.  
 
Swine Cerebral Venous Vasculature 
 The cerebral drainage system of the pig was well visualized using high resolution 3D 
TOF MR arteriovenography and 3D VIBE (figure 8.5). For our purposes, the similarity between 
humans and the pig brain anatomical and vascular structures is notable in the area of the 
thalamostriate veins, vein of Galen, and straight sinus (figure 8.5a). Figure 8.5 highlights the 
drainage of the DSS (analogous to the superior sagittal sinus), which drains the superficial veins 
of the brain. The SS drains the inferior sagittal sinus as well as the central cerebral vein and the 
basal vein. The SS joins the DSS at the torcular herophili, and bifurcates primarily into the 
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transverse sinuses as seen in figure 8.5b. Figure 8.6 on the other hand displays cross sections of 
the brain's vasculature using susceptibility weighted imaging, which is known to reveal the 
venous microvasculature. Figure 8.6a shows the superficial cerebral veins while figure 8.6b and 
8.6c show an axial view revealing the thalamostriate system at the level of the basal ganglia and 
midbrain of the pig.  
 
Figure 8.1: The venous drainage system of the swine reported in the literature. The solid lines 
show what was reported by Ghoshal et al. 1986 and the dashed lines show what was reported by 
Lavoie et al. 2008. *The author did not report any continuity of the petrosquamous sinus. 
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Figure 8.2:  T2 weighted images showing an axial cross section along the whole brain, revealing 
good contrast between white matter, gray matter and CSF similar to that seen in humans. 
 
Figure 8.3:  T1 weighted images showing an axial cross section along the whole brain, revealing 
good contrast between white matter, gray matter and CSF similar to that in humans. 
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Figure 8.4:  T1 weighted images showing coronal, axial and sagittal views (left to right) 
displaying different structures of the brain and the spinal cord. 
 
 
Figure 8.5:  A and B - 3D post contrast MRV, C - 3D VIBE. Dorsal sagittal sinus (DSS) (black 
arrow); internal cerebral vein (white chevron), thalamostriate system (black chevron); straight 
sinus (SS) (white arrow); cerebral superficial veins (white arrow head); transverse sinuses (black 
arrow head). 
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Figure 8.6:  Left and middle - SWI, Right - T1 weighted images post contrast. Superficial 
cerebral veins (white arrow head) and thalamostriate system (black arrow) draining through the 
internal cerebral vein into the vein of Galen back to the straight sinus (arrow head) in the pig (A-
C) and the human (D-F). 
 
The vasculature at neck level 
 Imaging the neck using axial 2D TOF MRV and 2D TOF MRA has revealed different 
components of the blood supply and blood drainage to and from the brain. Figure 8.7a shows the 
common carotid arteries which bifurcate into internal and external carotid arteries. The internal 
carotid arteries go on to supply the brain, while the external carotid arteries supply the frontal 
part of the head. Figure 8.7b, on the other hand, shows the external jugular veins which drain the 
104 
 
 
frontal part of the head. In addition, we see the internal jugular veins which drain the cavernous 
sinus back into the brachiocephalic trunk.  A large venous structure (figure 8.7c) is seen which 
represents a dominant drainage route from the brain, and runs parallel with the spinal cord. Many 
papers have referred to it as the ventral vertebral venous plexus (VVVP) or the paraspinal venous 
network (Lavoie et al., 2008). This is homologous to the epidural plexus in humans, however, in 
the supine position, the dominant outflow in the human is most commonly through the IJVs and 
in the upright position through the paraspinal network (Alperin et al., 2005).  In humans, the 
anterior condylar confluent allows for the redirection of blood flow between these vessels (San 
Millan Ruiz et al., 2012), however this structure was not clearly noted in the vasculature of the 
pig.  Anastomoses of varying diameter were observed between the IJV, external jugular veins 
(EJV), and VVVP in all three pigs.   
 
The vasculature as a whole 
 Figure 8.8 displays the entire vasculature of the pig including both arteries and veins at 
the brain and neck levels as visualized on 2D TOF MRV data. As mentioned previously, the DSS 
drains all the superficial veins of the brain. The straight sinus, which drains the center of the 
brain, joins the DSS to drain into the transverse sinuses. The transverse sinuses run bilaterally 
and then bifurcate to rostral and basal branches, with the former running between the occipital 
lobe and the cerebellum and the latter running dorsal to the cerebellum. The rostral branch 
connects the transverse sinus to cavernous sinus, which drains into the IJV through the emissary 
veins. Conversely, the basal branch drains into the basilar sinus, which then drains into the 
VVVP (or known as paraspinal venous network). The IJVs then drain into the subclavian veins  
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Figure 8.7:  3D projection of the 2D MRV data set. (A,D): Common carotid artery (white arrow 
head); internal carotid artery (short white arrow); external carotid artery (long white arrow); 
(B,E): internal jugular vein (short black and grey arrows); external jugular vein (long black and 
grey arrow) and (C,F): ventral vertebral venous plexus or also known as paravertebral veins 
(black and grey arrow head) in pigs (A-C) and human subject (D-F). 
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Figure 8.8:  Detailed anatomical description of the drainage system of the swine brain as shown 
in a 3D projection of the 2D TOF MRV data set. 
 
 
 
 
 
 
107 
 
 
back into the heart, while the VVVP travels down caudal posterior, draining the spine, and 
reaching the subclavian vein into the heart.  
 
Quantitative flow measurements of the vasculature of the head and neck 
Flow measurements at the mid neck level revealed a dominance of blood draining into 
the paraspinal veins compared to the internal or external jugular veins.  Table 8.2 details the 
quantitative flow measurements acquired at multiple levels in the head and neck for the male pig.  
DSS and the SS were collected on individual flow slices which were oriented perpendicular to 
the path of the vessel.  The flow through the DSS was greater than the flow through the SS at a 
ratio of 2.5:1 with the DSS carrying 0.28ml/s and the SS carrying 0.11ml/s of blood.  Draining 
from the confluence of these two sinuses, asymmetry was found in the right and left transverse 
sinus.  The left was the strongly favored flow pathway carrying 0.46ml/s as the right transverse 
sinus was found to carry 0.02ml/s.   
As detailed above, the transverse sinus can drain to the cavernous sinus.  A flow slice was 
also positioned through the ophthalmic sinuses connection to the cavernous sinus as they were 
observed to be large structures.  These structures carried greater flow than the dural sinus, with 
the right ophthalmic sinus showing 0.69ml/s and the left 0.65ml/s.  Combining the flow from the 
transverse sinus and ophthalmic sinus, it was estimated that flow through the cavernous sinus 
was approximately 1.80ml/s; however it should be noted that smaller veins which drain to the 
cavernous sinus were not included.  The major outflow route from the brain in the pig has been 
previously thought to be through the VVVP and separately through the emissary veins leading to 
the IJV.  The quantitative flow measurements suggest that this is true, with the IJV carrying a  
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Table 8.1:  Imaging parameters for the sequences collected during MR scanning.   
Abbreviations:  TOF=time of flight; PC=phase contrast; VIBE=volumetric breath-hold 
examination; TR=repetition time; TE=echo time; FA=flip angle; BW=bandwidth; FOV=field of 
view; TH=thickness. *Tracking F special saturation pulse was applied to acquire 2D MRV data.  
 
Sequence 
2D TOF 
MRAV* 
2D PC 
MR 
3D TOF 
MR`AV 
3D 
VIBE 
2D 
T2WI 
3D 
T1WI 
2D T2 
FLAIR 
SWI 
Orientation axial 
orthogonal 
to vessel 
axial sagittal axial coronal axial axial 
TR (ms) 23 12 28 3.97 5000 1750 7000 29 
TE (ms) 5.02 5.4 5 1.43 82 2.98 129 20 
FA (degrees) 60 15 30 25 120 9 150 15 
BW (Hz/pixel) 217 248 181 685 222 181 296 121 
FOV (mm
2
) 256x256 256x256 256x256 349x273 128x96 256x256 128x96 256x192 
Matrix Size 512x512 448x448 1024x1024 384x300 256x192 512x512 256x192 512x384 
Resolution 
(mm
2
) 
0.5x0.5 0.6x0.6 0.25x0.25 0.9x0.9 0.5x0.5 0.5x0.5 0.5x0.5 0.5x0.5 
Slice TH (mm) 2.5 4 0.5 0.9 2 1 2 1 
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Table 8.2: Quantitative flow measurements acquired at multiple levels in the head and neck for 
the male pig.  Data shown reflects the flow acquired on 7 separate phase contrast MRI slices. 
Vessel name 
Right Sided 
Flow (ml/s) 
Left Sided 
Flow (ml/s) 
Combined 
Flow (ml/s) 
Intracranial Venous Vasculature 
Dorsal sagittal sinus 0.28 0.28 
Straight sinus 0.11 0.11 
Total for mid-line dural sinus 0.39 0.39 
Transverse sinus 0.02 0.46 0.48 
Opthalmic sinus 0.67 0.65 1.32 
Total flow to cavernous sinus 0.69 1.11 1.80 
Extracranial Venous Vasculature as it exits the cranium 
Emissary vein of internal jugular vein 0.26 0.68 0.94 
Ventral vertebral plexus 0.51 0.59 1.10 
External jugular vein 0.49 0.43 0.92 
Anterior facial vein 0.02 0.30 0.32 
Total flow exiting cranium 1.28 2.00 3.28 
Extracranial Venous Vasculature at the inner base of the skull 
Internal jugular vein 0.23 0.66 0.89 
Ventral vertebral plexus 1.01 0.77 1.78 
External jugular vein 0.53 0.57 1.10 
Anterior facial vein 0.36 1.04 1.40 
Total flow at the inner base of the skull 2.13 3.04 5.17 
Extracranial Venous Vasculature at the outer base of the skull 
Internal jugular vein 0.23 0.64 0.87 
Ventral vertebral plexus 0.66 0.95 1.61 
External jugular vein 1.11 0.36 1.47 
Anterior facial vein 0.55 0.97 1.52 
Total flow at the outer base of the skull 2.55 2.92 5.47 
Extracranial Venous Vasculature at the C1 vertebral level 
Internal jugular vein 0.40 1.41 1.81 
Ventral vertebral plexus 0.94 1.05 1.99 
External jugular vein 0.93 0.87 1.80 
Anterior facial vein 0.00 0.49 0.49 
Total flow at the C1 vertebral level 2.27 3.82 6.09 
Extracranial Venous Vasculature at the C4 vertebral level 
Internal jugular vein 0.10 1.58 1.68 
Ventral vertebral plexus 1.37 1.31 2.68 
External jugular vein 0.99 1.48 2.47 
Total flow at the C4 vertebral level 2.46 4.37 6.83 
Extracranial Venous Vasculature at the C7 vertebral level 
Internal jugular vein 0.24 1.92 2.16 
Ventral vertebral plexus 1.62 1.64 3.26 
External jugular vein 1.28 1.30 2.58 
Total flow at the C4 vertebral level 3.14 4.86 8.00 
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Table 8.3: Comparison of the distribution of flow through the major veins of the neck for all 
three pigs. Values shown are percentage of total venous flow quantified for a given level in a 
given pig, therefore the percentages will add to 100 for each pig.  Abbreviations: R=right sided; 
L=left sided; IJV=internal jugular vein; EJV; external jugular vein; VVVP=ventral vertebral 
venous plexus; AFV=anterior facial veins. 
Parameter Pig 1 Pig 2 Pig 3 Average (St Dev) 
Sex Male Female Female   
Age 7 months  5 months  6 months    
Weight 23 kg   21 kg 22 kg    
  Foramen Magnum Flow Results 
R-IJV 4.2 11.0 5.0 6.8 (3.7) 
L-IJV 11.7 8.5 4.4 8.2 (3.7) 
R-EJV 20.4 12.5 19.6 17.5 (4.3) 
L-EJV 6.6 19.1 18.8 14.8 (7.1) 
R-VVVP 12.1 13.9 14.3 13.4 (1.2) 
L-VVVP 17.4 18.9 27.2 21.2 (5.3) 
R-AFV 10.1 5.7 4.2 6.7 (3.0) 
L-AFV 17.4 10.5 6.5 11.4 (5.6) 
  C3/4 Flow Results 
R-IJV 1.5 0.1 1.6 1.1 (0.8) 
L-IJV 23.1 14.4 2.2 13.2 (10.5) 
R-EJV 14.5 13.7 22.8 17.0 (5.0) 
L-EJV 21.7 29.4 30.1 27.1 (4.7) 
R-VVVP 19.2 16.6 19.9 18.6 (1.7) 
L-VVVP 20.1 25.7 23.3 23.0 (2.8) 
  C6/7 Flow Results 
R-IJV 2.9 1.3 1.6 1.9 (0.9) 
L-IJV 23.4 16.5 2.3 14.1 (10.7) 
R-EJV 19.8 19.9 26.4 22.0 (3.8) 
L-EJV 20.0 25.2 29.2 24.8 (4.6) 
R-VVVP 15.6 16.5 18.7 16.9 (1.6) 
L-VVVP 18.3 20.6 21.8 20.2 (1.8) 
 
combined 0.89ml/s and the VVVP 1.10ml/s of flow on a flow slice positioned perpendicular to 
flow as it exits the cranium.  Asymmetry was found in the flow between the right and left IJV 
with a ratio of 2.6:1 while the flow in the VVVP had a ratio of 1.2:1 with left sided dominance.   
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A comparison of the flow through the major veins of the neck for all three pigs is shown 
in Table 8.3.  Flow was normalized to total venous flow quantified in order to limit bias due to 
potential differences in total flow between pigs.  Veins were classified as: VVVP, IJV, EJV, and 
anterior facial veins (AFV).  The AFV represented a diverse group of veins including those 
within the superficial, ventral region as well as those surrounding the trachea and esophagus.   
The EJV included were lateral vessels which appeared to drain the nose and superficial tissues.  
The IJV were identified as the continuation of the emissary vein originating from the cavernous 
sinus, and their close proximity to the internal and common carotid arteries were also evident.  
The VVVP were identified as those vessels surrounding the dural sac and also, when observed, 
smaller vessels in the paraspinal region.  Some vessels were excluded due to their small size as a 
definite contour was not identified.   
Flow at the outer base of the cranium shows that the VVVP carried the largest portion of 
total venous outflow, and in each of the three pigs a left sided dominance was observed.  The 
EJV and AFV carried high flow as well, carrying a combined flow of around half of the total 
venous outflow quantified in each of the three pigs (50.5+/-3.6%).  Flow through the IJV was 
lower than the EJV or VVVP, and shows the highest variability compared to the other vessels.  
The pigs show three different trends for the IJV flow: left sided, right sided and bilateral 
dominance.  In pig 3, the lowest IJV flow was quantified and an increase of flow through the left 
VVVP was observed without a clear increase in flow through the other vessels.   
Flow at the lower neck levels of C3/4 and C6/7 demonstrated the dominance of outflow 
through the EJV as flow drained into these vessels from the superficial tissues and smaller veins 
of the face (the AFV were not clearly observed at these levels). The flow through the left IJV had 
the highest variability.  In two pigs, it carried a large portion of venous outflow (23.4% and 
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16.5%); however, in one of the female pigs it carried low flow (2.3%).  The right IJV was found 
to carry low flow in all three pigs, including pig 2 which had right sided IJV dominance at the 
base of the cranium.  The right and left EJV carried relatively symmetric flow compared to the 
IJV with the left EJV carrying slightly more in each of the three pigs.  The EJV drained between 
39.8% of total venous outflow in the male pig to 55.6% in one of the female pigs.  The VVVP 
carried a consistently large portion of the total venous outflow in each of the three pigs. As 
observed in the EJV, the right VVVP carried slightly less flow than the left.   
 
Discussion 
 The main goal of this work was to visualize and understand the cerebral vasculature of 
the pig brain, its drainage and whether a vascular animal model is feasible for vascular related 
neurological diseases. In a previous study, Wang el al. (Wang et al., 2010) worked on 
establishing a cerebral sinus thrombosis animal model, where a thrombin was injected into the 
DSS of the pig. This work revealed bilateral parasagittal infarction as well as edema, the same as 
seen in humans using MRI. They concluded that pigs can be used as an animal model for 
cerebral sinus thrombosis to understand the associated pathophysiology and to develop better 
therapeutic approaches. In another study, Chai el al. (Chai et al., 1995) designed an experiment 
to test whether jugular venous ligation can change the intraluminal and intracranial pressures and 
hemispheric cerebral blood flow and whether removing the ligation will reverse the effect. His 
work showed that this procedure did increase cerebral blood flow but there was no increase in 
jugular venous pressure or intracranial pressure. These results can be explained by the fact that 
the main venous drainage system in swine is the ventral vertebral venous plexus as seen in this 
paper and in Lavoie et al. (Lavoie et al., 2008). In the latter paper, the authors identified an 
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anteriorly and rostrally coursing vein, named the petrosquamous sinus, which mainly drains into 
the retromandibular vein. In homo sapiens, the petrosquamous sinus is an embryological remnant 
structure which typically recedes during fetal development, its continued presence being linked 
to increased incidence of infection and symptoms such as vertigo.  Also notable was that Lavoie 
et al. did not show any link between intracranial venous structures and the internal jugular veins. 
This link, on the other hand, was seen in our results through the cavernous sinus which drains 
into the jugular vein. Similar patterns have been described ex vivo in Ghoshal et al. (Ghoshal and 
Zguigal, 1986). In addition, anastomoses have been identified in our data between the vertebral 
venous plexus and the jugular veins in all three pigs, as well as anastomoses which bilaterally 
link the IJV. These results suggest that the reason Chai et al. (Chai et al., 1995) failed to see any 
increase in venous or intracranial pressure was because the main drainage from the brain takes 
place through the vertebral venous plexus which can link back to the IJV. However, if we 
occlude the ventral vertebral veins at the most cranial segment available, this might lead to the 
expected increase in intracranial pressure and a form of chronic venous hypertension. 
In this respect, the use of pig as a vascular model for chronic venous hypertension is 
plausible.  Although further research is warranted, there are still clear vascular differences 
between the pig and human.  The ideal effect of creating the potentially causative or exacerbating 
forces generated in MS patients exhibiting chronic cerebrospinal venous insufficiency (CCSVI) 
has not yet been shown; however the model template is now well understood.  In pigs, drainage 
of blood flow does not appear to be dominated by that from the brain as it is in the neck of 
humans. Large amounts of blood flow appear to collect in the vessels from the superficial muscle 
and fat pad of the pig, as well as a large supply of blood draining from the olfactory, ocular, and 
gustatory tissues.  This flow appears to drain primarily into the EJV and AFV, but the venous 
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system of the pig is dynamic and contains connections between dominant outflow routes.  Blood 
flow does drain from the brain into the VVVP and to the IJV; however, this flow could 
potentially become collateralized.  In order to successfully obstruct blood drainage from the 
brain, careful evaluation of the pig’s vasculature and precise occlusion techniques would be 
needed to ensure that appropriate stress is induced in the venous system.  
The results indicate that the positioning of the pig during scanning had an effect on the 
overall flow in the extracranial vessels.  As the pig was oriented on the right side, this may have 
compressed the vessels in the neck and redirected blood flow into alternative pathways.  This 
may be a possible explanation for the low blood flow observed in the right IJV compared to the 
left side at the lower neck levels. This type of adaption has also been evidenced in the neck of 
humans, however, further research is needed to explain what effect this may have on intracranial 
pressure and CCSVI.  
A limitation of this study is that the quantitative flow data is not cardiac gated because of 
the very rapid heart rate under sedation.  Therefore, this limits the picture of whether reflux or 
bidirectional flow is present in the venous system as well as obscures the ability to assess the 
cerebrospinal fluid oscillatory profile.  Despite this, MRI allows for the quantification of blood 
flow on average, and when normalized to total arterial flow can give indications of the 
redirection of blood flow in the presence of obstruction in the dominant, venous outflow routes 
in comparison to the baseline explained in this work.   
In conclusion, we have shown that MRI can provide a complete visualization of the 
cerebral venous drainage system and its function in the pig brain and neck. Blood flow can be 
quantified and the proportion of blood leaving the brain through the vertebral venous plexus and 
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internal jugular vein analyzed. The structures seen suggest that in order to initiate a stress on the 
venous system in the brain, the large ventral vertebral venous plexus will need to be occluded. 
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Chapter Nine 
CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
In this thesis, we used a modern 3T MR whole body human spectrometer to study one of 
the most important molecules in the brain, iron, and its manifestation in multiple sclerosis. Due 
to its magnetic characteristics, we were able to visualize and resolve the brain structures and sub-
structures in vivo using a new technique known as susceptibility weighted imaging.  This 
technique presented a better contrast and differentiation compared to conventional MR 
sequences. Its accuracy was validated quantitatively against one of the most dependable iron 
imaging techniques, X-Ray fluorescence, where we showed similar contrast in both methods. In 
this same study where we used MS cadaver brains, we were also able to report the presence of 
iron in MS lesions and other brain structures using both methodologies. 
Taking it one step further, we assessed iron content in the midbrain and basal ganglia 
structures in MS patients compared to normal controls. We presented a new post processing 
approach to evaluate iron in the structure of interest. Our results showed an increase in iron 
content in several structures of MS brains compared to healthy subjects. Specifically, we were 
able to distinguish the red nucleus as being the most affected structure in older MS patients, 
while increases in iron in the pulvinar thalamus was more dominant in younger subjects.  
  Finally, we studied the similarities between the human and the pig cerebrovascular 
drainage systems and their routes to the heart through the neck vessels, as a means to create a 
new animal model for MS linking iron and lesion development to vascular abnormalities. We 
reported the differences, which were minor, making this model a good approach to test the 
vascular theory. My major efforts in the published work of chapters 4, 6, 7 and 8 were in 
designing the experiments followed by data acquisition and analysis. The next step of this project 
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is underway, and we will give a brief update on the status of that study and where we are heading 
as part of this work’s future direction. 
 
Future directions:  
Iron in the brain 
In this thesis, we presented a new approach to assess iron content in the brain of MS 
patients compared to normal subjects using phase images from SWI data. Although phase was 
able to reveal abnormal iron deposition in MS patients, phase is geometry dependent. The next 
step will be to repeat this analysis using a new phase post processing technique known as 
susceptibility weighted imaging and mapping (SWIM) that removes this geometry dependence 
and gives a magnetic source imaging measure of putative iron content. The resulting 
susceptibility map has in fact been shown to correlate well with iron content using XRF and 
other means. The previous phase data can be used to restudy the same group of MS patients we 
originally evaluated. These SWIM data will make it possible to measure iron throughout a given 
structure not just in one slice as in the previous work. 
 
Multiple Sclerosis: a vascular model 
The direct relationship between venous obstruction, iron deposition and inflammation 
(and hence tissue damage and lesion development), has not been well studied, however, every 
piece of this puzzle has a strong stand-alone role in MS research. A review of the literature from 
the past century presents decent evidence that this new vascular theory might explain some of the 
MS landmarks including immunological responses, vessel wall breakdown and iron deposition in 
lesions and in the deep gray matter. 
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In order to address this conflict with a convincing scientific methodology, one of the best 
approaches is to develop an animal model that has similar blood drainage behavior as humans, 
create vascular obstructions at different degrees to stress the cerebral venous system, and monitor 
the different aspects of venous hypertension, reduced blood flow in the brain and any developing 
sclerotic lesions. Changes in blood flow and iron can be monitored with MR angiography, MR 
venography, quantitative flow imaging and SWI. In a clinical setting, knowing the start point is 
never possible; by the time the patient has a series of symptoms, the damage has already taken 
place. Therefore, the ability to visualize and monitor structural and functional changes in this 
model using MRI might give us the chance to create a chronological order of the pathological 
pathways seen in MS.  
All the steps of this proposed direction have been independently reported in the literature, 
including: similarities between the human and pig venous drainage systems (Ghoshal and 
Zguigal, 1986; Si et al., 2008; Zezula-Szpyra and Grzegorzewski, 2000), the application of 
venous occlusions (Schutze et al., 2007), the resulting venous hypertension in swine (Lavoie et 
al., 2008) and lesion development in dogs (Putnam, 1935). Currently, we are following two 
Yucatan micropigs, one with induced stenosis and the other as a companion normal control. In 
our proposed implementation of this approach, the pigs were be scanned repeatedly after ligation 
at post op, 3 and 6 months respectively to monitor cerebral perfusion and lesion development. 
Quantitative measures will be made for vessel lumen and flow for all the major veins and arteries 
feeding the brain to measure the cardiovascular input/output. Lesion load if seen will be 
compared to the flow abnormalities. However, the simple presence of lesions will be considered 
a major finding assuming that no lesions are present in baseline imaging. (More details of this 
new direction can be found in Appendix 2.) 
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In conclusion, MS is one of the most complex neurodegenerative diseases, with many 
contributing factors. Any promising approach should be investigated if it has the potential to 
enhance the patient’s quality of life. We hope that this work will add a piece to the MS puzzle, 
whether it is through a better understanding of the role iron plays or by creating an animal model 
that will lead to a better understanding of the role abnormal venous vasculature plays as a 
comorbidity in multiple sclerosis. 
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APPENDIX A 
PHASE CONTRAST QUANTITATIVE FLOW IMAGING 
Introduction 
Phase contrast (PC) is an MR imaging technique that has long been used to quantify flow 
parameters in vivo non-invasively. It is mainly applied to image blood and cerebrospinal fluid 
flow assessing local velocity. The basic concept is the use of flow encoding gradients to translate 
phase into velocity information. The application of those gradients (bipolar gradients) yields a 
linear proportionality between velocity and phase, hence they are known as velocity encoding 
gradients (Moran et al., 1985). In this appendix, we will briefly go through the link between 
phase and velocity given that we used this method in chapter 8 to draw a map of blood flow in 
the pig model. 
The bipolar gradient is usually applied in the direction of the flow of interest Figure 
(A.1). The gradients are applied in one of the three logical gradient axes (read encoding, phase 
encoding or partition encoding direction) or can be applied along two or more if any arbitrary 
direction is desired. These bipolar gradients are usually added to conventional gradient echo 
sequences (Bernstein et al., 2004). However, we know from chapter 3 that there are other 
contributors to the phase component in GRE sequences (such as field inhomogeneity). Therefore, 
PC acquires two sets of data with the same exact parameters, except for the first moment of the 
bipolar gradients. The phase images from these two data sets are subtracted on a pixel by pixel 
basis, accentuating the flow while suppressing all other sources of unwanted phase information. 
In doing these subtractions, two methods are commonly used and known as phase difference 
(PD) and complex difference methods. Although the latter is less sensitive to partial volume 
effects, the former depicts the direction of the flow and contains information about the volume 
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flow rate. Given our interest with PD, we will go on to explain how it works after we introduce 
the link between phase and velocity. 
 
Figure A.1: Typical Phase contrast Pulse Sequence (Bernstein et al., 2004) 
 
The amount of velocity encoding is manifest in the change in the gradient first moment 
(Δm1). The relationship between the change in phase and Δm1 is given by: 
 
Δφ = γΔm1ν       (A.1) 
 
To set the dynamic range for the phase difference, the operator is asked to prescribe a parameter 
known as velocity encoding (νenc), which is also known as the aliasing velocity. In other words, 
νenc is defined as the velocity corresponding to a change in phase of π. From eq. A.1, we get: 
γΔm1νenc = π       (A.2) 
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Combining equations A.1 and A.2 yields:  
 
Δφ = (ν/ νenc)*π       (A.3) 
 
The choice of νenc (cm/s) depends on the amount of flow we are interested in measuring. A high 
νenc gives higher dynamic range, however it reduces sensitivity to low flow. On the other hand, 
low νenc gives higher sensitivity but leads aliasing when |ν| > |νenc|.
  
 The difference in phase Δφ is calculated using the PD reconstruction method that we 
mentioned earlier. This approach uses the phase information in the image domain and applies a 
pixel by pixel subtraction to yield a Δφ map (Haacke, 1999). In the cases where |ν| < |νenc|, the 
quantitative value of the velocity can be extracted from:  
 
ν = (Δφ/π)* νenc       (A.4) 
 
In the case of aliasing, however, the velocity will be underestimated and therefore, appropriate 
anti-aliasing algorithms should be applied prior to PD reconstruction. 
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APPENDIX B 
PROGRESS TO DATE OF THE VASCULAR ANIMAL MODEL OF MS 
 
The three pigs initially imaged to understand the cerebral venous drainage system were 
considered as animal subjects to test the hypothesis. The surgery of the first pig was done and 
has achieved a complete occlusion of the right vertebral vein and a partial occlusion of the left 
vertebral vein (figure B.1 – post op 1 – red arrow). This process has helped decreasing the blood 
drainage from the brain by 20%. In a second attempt, we were successful in occluding all the 
jugular veins (internal and external) (post op 2 - red arrows). MR scans were and will be repeated 
every three months to visualize any lesion development as an association between venous 
abnormalities and brain damage in MS (figure B.1).  
In this follow up, we have seen the development of collaterals (blue arrows) around the 
occluded vessel, which is reported in the majority of patients with vascular drainage 
abnormalities, giving us the confidence that we are on the right track. We aim to do quantitative 
measures for vessel lumen and flow for all the major veins and arteries feeding the brain to 
measure the cardiovascular input/output. Lesion load if seen will be compared to the flow 
abnormalities. However, the simple presence of lesions will be considered a major finding 
assuming that no lesions are present in baseline imaging. 
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Figure B.1: The venous drainage system pre and post-surgery (5, 9 and 13 months follow-up). 
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APPENDIX C  
THE JOHN WILEY AND SONS LICENSE TERMS AND CONDITIONS  
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 The importance of iron in maintaining normal physiological processes in the human body 
has been well emphasized in the literature. However, "when iron behaves badly", its abnormal 
presence might lead to a spectrum of pathologies depending on what function has been altered. 
In the brain, for instance, abnormal iron content is thought to be associated with 
neurodegenerative diseases. In this dissertation, we study iron involvement in one of the most 
debilitating neurological diseases, multiple sclerosis (MS), using in vivo magnetic resonance 
imaging. We first test the sensitivity and specificity of the MR method used, known as 
susceptibility weighted imaging (SWI) compared to other conventional MR techniques and 
rapid-scanning X-ray fluorescence in MS cadaver brains. Then, we use SWI phase images to 
assess iron content in the deep gray matter structures of MS patients compared to normal 
controls. Finally, we assess the possibility of developing a new MS vascular animal model to 
study the link between vascular abnormalities, iron deposition and sclerotic lesions. 
As a result of this work, we show that SWI provides a better contrast to image the 
structures and substructures of the brain based on their iron content compared to conventional 
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MR techniques. The power of SWI in imaging iron content was validated by the use of X-Ray 
fluorescence (which is known to be an element specific imaging method), showing similar 
contrast and making SWI the method of choice to image iron content in vivo. Using SWI, we 
show a clear separation between MS patients and normal subjects, when we assessed iron 
content in the midbrain, thalamus and basal ganglia. We report that out of the seven structures 
studied, two were more susceptible to abnormal iron deposition (the pulvinar thalamus in young 
adults, and the red nucleus in elderly people). Finally, in an MR based study, we show that the 
swine and the human share a similar cerebrovascular drainage system starting from the 
superficial cerebral veins and deep cervical veins all the way to the heart, aiming to use this 
model to test the vascular involvement in MS. 
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